<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="research-article" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Endocrinol.</journal-id>
<journal-title>Frontiers in Endocrinology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Endocrinol.</abbrev-journal-title>
<issn pub-type="epub">1664-2392</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fendo.2024.1399274</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Endocrinology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Differential involvement of cAMP/PKA-, PLC/PKC- and Ca<sup>2+</sup>/calmodulin-dependent pathways in GnRH-induced prolactin secretion and gene expression in grass carp pituitary cells</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Li</surname>
<given-names>Wensheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/144915"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Ye</surname>
<given-names>Cheng</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn004">
<sup>&#x2021;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/568569"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Mulan</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Ko</surname>
<given-names>Wendy K. W.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/investigation/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/software/"/>
<role content-type="https://credit.niso.org/contributor-roles/validation/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cheng</surname>
<given-names>Christopher H. K.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<xref ref-type="author-notes" rid="fn003">
<sup>&#x2020;</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/34113"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Chan</surname>
<given-names>Ying Wai</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1224298"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/visualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Wong</surname>
<given-names>Anderson O. L.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="author-notes" rid="fn001">
<sup>*</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/26284"/>
<role content-type="https://credit.niso.org/contributor-roles/conceptualization/"/>
<role content-type="https://credit.niso.org/contributor-roles/data-curation/"/>
<role content-type="https://credit.niso.org/contributor-roles/formal-analysis/"/>
<role content-type="https://credit.niso.org/contributor-roles/funding-acquisition/"/>
<role content-type="https://credit.niso.org/contributor-roles/methodology/"/>
<role content-type="https://credit.niso.org/contributor-roles/project-administration/"/>
<role content-type="https://credit.niso.org/contributor-roles/resources/"/>
<role content-type="https://credit.niso.org/contributor-roles/supervision/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>School of Biological Sciences, The University of Hong Kong</institution>, <addr-line>Hong Kong</addr-line>, <country>Hong Kong SAR, China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>School of Life Sciences, Sun Yat-Sen University</institution>, <addr-line>Guangzhou</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<sup>3</sup>
<institution>School of Biomedical Sciences, Chinese University of Hong Kong</institution>, <addr-line>Hong Kong</addr-line>, <country>Hong Kong SAR, China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>Edited by: Chun Peng, York University, Canada</p>
</fn>
<fn fn-type="edited-by">
<p>Reviewed by: Maho Ogoshi, Okayama University, Japan</p>
<p>Quan Jiang, Sichuan University, China</p>
<p>Hironori Ando, Niigata University, Japan</p>
</fn>
<fn fn-type="corresp" id="fn001">
<p>*Correspondence: Anderson O. L. Wong, <email xlink:href="mailto:olwong@hku.hk">olwong@hku.hk</email>
</p>
</fn>
<fn fn-type="deceased" id="fn003">
<p>&#x2020;Deceased</p>
</fn>
<fn fn-type="equal" id="fn004">
<p>&#x2021;These authors have contributed equally to this work</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>04</day>
<month>06</month>
<year>2024</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>15</volume>
<elocation-id>1399274</elocation-id>
<history>
<date date-type="received">
<day>11</day>
<month>03</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>05</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2024 Li, Ye, He, Ko, Cheng, Chan and Wong</copyright-statement>
<copyright-year>2024</copyright-year>
<copyright-holder>Li, Ye, He, Ko, Cheng, Chan and Wong</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Gonadotropin-releasing hormone (GnRH) is a key stimulator for gonadotropin secretion in the pituitary and its pivotal role in reproduction is well conserved in vertebrates. In fish models, GnRH can also induce prolactin (PRL) release, but little is known for the corresponding effect on PRL gene expression as well as the post-receptor signalling involved. Using grass carp as a model, the functional role of GnRH and its underlying signal transduction for PRL regulation were examined at the pituitary level. Using laser capture microdissection coupled with RT-PCR, GnRH receptor expression could be located in carp lactotrophs. In primary cell culture prepared from grass carp pituitaries, the native forms of GnRH, GnRH2 and GnRH3, as well as the GnRH agonist [D-Arg<sup>6</sup>, Pro<sup>9</sup>, NEt]-sGnRH were all effective in elevating PRL secretion, PRL mRNA level, PRL cell content and total production. In pituitary cells prepared from the rostral pars distalis, the region in the carp pituitary enriched with lactotrophs, GnRH not only increased cAMP synthesis with parallel CREB phosphorylation and nuclear translocation but also induced a rapid rise in cytosolic Ca<sup>2+</sup> by Ca<sup>2+</sup> influx via L-type voltage-sensitive Ca<sup>2+</sup> channel (VSCC) with subsequent CaM expression and NFAT<sub>2</sub> dephosphorylation. In carp pituitary cells prepared from whole pituitaries, GnRH-induced PRL secretion was reduced/negated by inhibiting cAMP/PKA, PLC/PKC and Ca<sup>2+</sup>/CaM/CaMK-II pathways but not the signalling events via IP<sub>3</sub> and CaN/NFAT. The corresponding effect on PRL mRNA expression, however, was blocked by inhibiting cAMP/PKA/CREB/CBP and Ca<sup>2+</sup>/CaM/CaN/NFAT<sub>2</sub> signalling but not PLC/IP<sub>3</sub>/PKC pathway. At the pituitary cell level, activation of cAMP/PKA pathway could also induce CaM expression and Ca<sup>2+</sup> influx via VSCC with parallel rises in PRL release and gene expression in a Ca<sup>2+</sup>/CaM-dependent manner. These findings, as a whole, suggest that the cAMP/PKA-, PLC/PKC- and Ca<sup>2+</sup>/CaM-dependent cascades are differentially involved in GnRH-induced PRL secretion and PRL transcript expression in carp lactotrophs. During the process, a functional crosstalk between the cAMP/PKA- and Ca<sup>2+</sup>/CaM-dependent pathways may occur with PRL release linked with CaMK-II and PKC activation and PRL gene transcription caused by nuclear action of CREB/CBP and CaN/NFAT<sub>2</sub> signalling.</p>
</abstract>
<kwd-group>
<kwd>GnRH</kwd>
<kwd>prolactin</kwd>
<kwd>hormone secretion</kwd>
<kwd>gene expression</kwd>
<kwd>signal transduction</kwd>
<kwd>pituitary cells</kwd>
<kwd>grass carp</kwd>
</kwd-group>
<counts>
<fig-count count="13"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="88"/>
<page-count count="24"/>
<word-count count="13535"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-in-acceptance</meta-name>
<meta-value>Experimental Endocrinology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec id="s1" sec-type="intro">
<label>1</label>
<title>Introduction</title>
<p>Gonadotropin-releasing hormone (GnRH), a member of the GnRH/AKH/CRZ superfamily, is an ancient hormone evolved prior to the divergence of protostomes and deuterostomes (<xref ref-type="bibr" rid="B1">1</xref>). In vertebrate species, three forms of GnRH have been identified, namely GnRH1, GnRH2 and GnRH3, and believed to be arose from whole genome duplication occurred in ancestral vertebrates (<xref ref-type="bibr" rid="B2">2</xref>). Given that multiple forms of GnRH structurally comparable to vertebrate GnRHs can be identified in tunicates, the possibility of GnRH gene duplication occurred during the evolution of protochordate cannot be excluded (<xref ref-type="bibr" rid="B3">3</xref>). The three isoforms of GnRH in vertebrate species are highly conserved in a.a. sequence, expressed in a species-specific manner in neurons within different brain areas, and proposed to have overlapping and yet distinct functions caused by subfunctionalization of the respective paralogs (<xref ref-type="bibr" rid="B4">4</xref>). In mammals, GnRH1 is the major form and GnRH3 was lost during evolution, whereas GnRH2 can be found in some species (e.g., human and monkey) but not the others (e.g., rodents). In tetrapods like the amphibians, reptiles and birds, GnRH3 was also lost with only GnRH1 and GnRH2 expressed. In fish, different combinations of the three isoforms can be noted, e.g., GnRH1 and GnRH2 in catfish and eel, GnRH2 and GnRH3 in salmon, goldfish and zebrafish, and three forms of GnRH in sea bass, medaka and tilapia (<xref ref-type="bibr" rid="B3">3</xref>, <xref ref-type="bibr" rid="B4">4</xref>). At present, our understanding on the neuro-anatomical distribution and differential functions of different GnRH isoforms is mainly based on the studies in fish models (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). In fish with three forms of GnRH (e.g., sea bass), GnRH1 neurons are located in the preoptic area within the brain with notable innervation in the pituitary while GnRH3 neurons are scattering along the terminal nerve, ventral telencephalon and preoptic area with a low level of pituitary innervation. GnRH2 neurons, however, are confined within the midbrain tegmentum with little/no fibres innervating the pituitary (<xref ref-type="bibr" rid="B7">7</xref>). Similar to fish models, localization of GnRH1 neurons in the preoptic area (&amp; GnRH2 neurons in the midbrain area of some species) is well-conserved in mammals (<xref ref-type="bibr" rid="B8">8</xref>, <xref ref-type="bibr" rid="B9">9</xref>).</p>
<p>In general, the GnRH1 neurons in the preoptico-hypothalamic tract represent the major source of GnRH for gonadotropin regulation at the pituitary level whereas GnRH2 and GnRH3 from other brain areas are commonly accepted to be neurotransmitters/neuromodulators with other functions related to reproduction (<xref ref-type="bibr" rid="B4">4</xref>, <xref ref-type="bibr" rid="B9">9</xref>). For examples, GnRH2 from the midbrain area is involved in sexual behaviours, appetite control, steroidogenesis, and implantation/placental functions, and probably also coordinates the interaction between nutritional status and sexual activities (<xref ref-type="bibr" rid="B10">10</xref>). Meanwhile, GnRH3 originated from the terminal nerve ganglia has been proposed to play a role in relaying the sensory input from the olfactory bulbs (via olfactory tract) and visual system (from optic tectum) with reproductive functions (<xref ref-type="bibr" rid="B4">4</xref>). In medaka, GnRH1 neurons with pituitary innervation exhibit episodic bursting of action potentials related to the reproduction cycle, which is different from the regular pattern of action potentials in GnRH2 and 3 neurons with intrinsic pacemaker activity (<xref ref-type="bibr" rid="B11">11</xref>). In the same model, the frequency of action potentials in GnRH1 neurons can be elevated with LH surge (<xref ref-type="bibr" rid="B12">12</xref>) and GnRH1 knockout inhibits ovulation and spawning activity in female fish (<xref ref-type="bibr" rid="B13">13</xref>). Episodic firing of GnRH1 neurons in the preoptic area has also been reported in tilapia (<xref ref-type="bibr" rid="B14">14</xref>), which is consistent with the idea of GnRH pulsatility caused by KNDy neuron network within the hypothalamus leading to episodic release of luteinizing hormone (LH) at the pituitary level (<xref ref-type="bibr" rid="B15">15</xref>). In fish models, the functional role of GnRH1 has been replaced by GnRH3 in fish species with only GnRH2 and GnRH3 expression (e.g., the cyprinids and salmonids). In goldfish, a member of the cyprinid family, GnRH3 neurons in the preoptic area have fibres penetrating into the pituitary (<xref ref-type="bibr" rid="B16">16</xref>) and GnRH3 is the key mediator for seasonal changes in LH secretion (<xref ref-type="bibr" rid="B17">17</xref>) and spawning activity (<xref ref-type="bibr" rid="B18">18</xref>). For GnRH2, besides its expression in the midbrain area, it is also expressed in the forebrain (including the preoptic area) as well as in the pituitary (<xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B20">20</xref>). In goldfish pituitary cells, interestingly, GnRH2 is more potent than GnRH3 in stimulating LH and follicle-stimulating hormone (FSH) expression (<xref ref-type="bibr" rid="B21">21</xref>). GnRH2 fibres (<xref ref-type="bibr" rid="B22">22</xref>) and protein signals (<xref ref-type="bibr" rid="B23">23</xref>) can also be detected in the pituitary of zebrafish but the source of GnRH2 is still unclear.</p>
<p>The biological actions of GnRH, especially for gonadotropin regulation, are mediated by GnRH receptor (GnRHR) functionally coupled with the PLC/IP<sub>3</sub>/PKC, AC/cAMP/PKA, PLA<sub>2</sub>/AA, PI3K/Akt, MAPK and Ca<sup>2+</sup>-dependent cascades (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>) and the post-receptor signalling involved, despite the species-specific variations, is highly conserved from fish to mammals (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). GnRHR is a member of the rhodopsin-like G protein-coupled receptor (GPCR), and its origin can be traced back to the early members of invertebrates (<xref ref-type="bibr" rid="B1">1</xref>). In vertebrate species, two types of GnRHR, GnRHR-I and GnRHR-II, can be identified and believed to be the result of a tandem duplication of GnRHR gene in ancestral gnathostome occurred prior to the multiple rounds of genome duplication during vertebrate evolution (<xref ref-type="bibr" rid="B28">28</xref>). Subsequent local duplication of GnRHR-II gene followed by additional gene duplication of GnRHR-I and -II along with the whole genome duplication (with 3 rounds in fish and 2 rounds in tetrapods) probably have led to the multiple subtypes of GnRHR-I and -II found in modern-day vertebrates (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B29">29</xref>). During the course of evolution, GnRHR-I is lost in bony fish and amphibians, while GnRHR-II is lost in most of the mammals (e.g., human and rodents) but retained in some primates (e.g., monkey) (<xref ref-type="bibr" rid="B2">2</xref>). Although GHRHR-I and -II share a notable level of sequence homology, the two receptors are structurally and functionally distinct from each other. By comparing with GnRHR-II, the 3<sup>rd</sup> intracellular loop is relatively shorter and the C-terminal tail typical of GPCR is missing in GnRHR-I (<xref ref-type="bibr" rid="B24">24</xref>). In expression studies using GnRHR-II with deletion of the C-terminal tail (<xref ref-type="bibr" rid="B30">30</xref>) and GnRHR-I with addition of C-terminal tail from GnRHR-II (<xref ref-type="bibr" rid="B31">31</xref>), GnRHR-I, unlike GnRHR-II, was found to be not sensitive to receptor desensitization caused by GnRH and this unique property associated with the lack of C-terminal tail has been recently proven to be essential for normal fertility in the mouse model (<xref ref-type="bibr" rid="B32">32</xref>). In general, GnRHR-I is specific for GnRH1 (e.g., mammals) (<xref ref-type="bibr" rid="B33">33</xref>) while GnRHR-II (e.g., fish species) is either with a preference for GnRH2 (<xref ref-type="bibr" rid="B34">34</xref>) or being promiscuous to the three forms of GnRH (<xref ref-type="bibr" rid="B35">35</xref>). Using site-directed mutagenesis and domain swapping in human/monkey GnRHRs, the extracellular loop 2 and 3 together with the residues located close to membrane surface in TMD4 and 7 were found to be the structural determinants for ligand selectivity against different forms of GnRH (<xref ref-type="bibr" rid="B36">36</xref>, <xref ref-type="bibr" rid="B37">37</xref>).</p>
<p>In fish models (e.g., tilapia), different subtypes of GnRHR-I and -II are expressed in pituitary cells other than gonadotrophs (<xref ref-type="bibr" rid="B38">38</xref>), and GnRH, besides its role as the gonadotropin-releasing factor, can also stimulate growth hormone (GH), prolactin (PRL) and somatolactin (SL) secretion at the pituitary level (<xref ref-type="bibr" rid="B27">27</xref>). The PRL response induced by GnRH is particularly interesting as PRL is involved in spawning migration (e.g., in salmon), nesting and brooding (e.g., in birds), parental care (e.g., mouth brooding in fish) and nutrient provision for the young (e.g., lactation in mammals and chick feeding in birds) (for reviews on reproductive functions of PRL, see (<xref ref-type="bibr" rid="B39">39</xref>, <xref ref-type="bibr" rid="B40">40</xref>)). Apparently, PRL induction by GnRH may serve as a signal input from the hypothalamo-pituitary axis to trigger the reproductive functions of PRL. Although PRL regulation by GnRH has also been reported in mammals, the information is restricted to PRL release and the results obtained are not consistent, as stimulatory (<xref ref-type="bibr" rid="B41">41</xref>&#x2013;<xref ref-type="bibr" rid="B43">43</xref>) and no effect have been documented (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). For stimulatory action, GnRH-induced PRL secretion could be associated with the elevation of IP<sub>3</sub> (<xref ref-type="bibr" rid="B46">46</xref>) and cAMP levels (<xref ref-type="bibr" rid="B47">47</xref>, <xref ref-type="bibr" rid="B48">48</xref>) or indirect action via local signals produced by gonadotrophs (<xref ref-type="bibr" rid="B49">49</xref>, <xref ref-type="bibr" rid="B50">50</xref>). Except for the limited studies in tilapia for PRL release (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>) and in salmon for PRL mRNA expression caused by GnRH (<xref ref-type="bibr" rid="B53">53</xref>, <xref ref-type="bibr" rid="B54">54</xref>), little is known for PRL regulation by GnRH in non-mammalian species. Despite a single report in tilapia confirming the involvement of PLC/IP<sub>3</sub>- and Ca<sup>2+</sup>-dependent mechanisms in GnRH-induced PRL secretion in fish model (<xref ref-type="bibr" rid="B51">51</xref>), the post-receptor signalling for the effect on PRL gene expression is still unknown. Given that (i) the reproductive functions of PRL are expected to have beneficial effects on induced spawning in commercial fish with GnRH treatment, and (ii) the studies on signal transduction mediating the PRL responses by GnRH are still fragmentary and restricted to PRL release, an <italic>in vitro</italic> study was initiated in carp pituitary cells to examine the pituitary action of GnRH and the post-receptor signalling for GnRH-induced PRL release and gene expression. In our study, grass carp was used as the animal model as it is a representative of the cyprinids with high market value in Asian countries (~5.8 million tonnes/year and accounts for 12% of global finfish culture, data from 2022 FAO Report for World Fisheries and Aquaculture). Based on our promoter analysis of grass carp PRL gene, one CRE site (with core sequence &#x201c;CGTCA&#x201d;), one AP-1 site (with core sequence &#x201c;TCAGTCA&#x201d;) and three NFAT binding sites (with core sequence &#x201c;GGAAA&#x201d;) can be identified in the proximal promoter upstream of the TATA box (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S1</bold>
</xref>), implying that PRL expression in carp pituitary is under the control of cAMP/PKA-, PLC/PKC- and/or Ca<sup>2+</sup>-dependent signalling. Using a pharmacological approach with parallel monitoring of second messengers and transcription factors linked with these signalling pathways, we have demonstrated for the first time that the cAMP/PKA, PLC/PKC and Ca<sup>2+</sup>/Calmodulin (CaM)-dependent cascades together with the crosstalk of cAMP/PKA pathway with CaM expression and Ca<sup>2+</sup> entry via voltage-sensitive Ca<sup>2+</sup> channels (VSCC) are differentially involved in PRL release and gene expression caused by GnRH via a specific subtype of GnRHR, namely GnRHR<sub>4</sub>, expressed in lactotrophs in the carp pituitary.</p>
</sec>
<sec id="s2" sec-type="materials|methods">
<label>2</label>
<title>Materials and methods</title>
<sec id="s2_1">
<label>2.1</label>
<title>Animals and test substances</title>
<p>One-year-old grass carp (<italic>Ctenopharyngodon idellus</italic>) with body weight of ~1.5 kg were purchased from local wholesale markets and acclimated for 5 days in well-aerated 200 L water tanks under a 12-hr light:12-hr dark photoperiod at 20&#xb0;C in our central aquarium prior to any experimentation. Since the fish available locally (with GSI &lt; 0.1%) were pre-pubertal and without sexual dimorphism based on external morphology, grass carp of mixed sexes were used in our pituitary cell preparation. During the process, the fish were anesthetized with MS222 (0.05%; Sigma-Aldrich, St. Louis, MO) followed by spinosectomy and routine procedures to obtain the pituitary from the sella turcica within the skull. The protocols for tissue sampling, pituitary cell preparation and associated <italic>in vitro</italic> experiments (CULATR 4608&#x2013;18) were approved by the Committee for Animal Use in Teaching and Research at the University of Hong Kong (Hong Kong).</p>
<p>Grass carp GnRH2 (formerly called chicken GnRH-II/cGnRH-II) and GnRH3 (formerly called salmon GnRH/sGnRH) as well as the superactive GnRH analog in fish models, namely [D-Arg<sup>6</sup>, Pro<sup>9</sup>, NEt]-sGnRH (sGnRH-A), were synthesized by Genscript Biotech (Piscataway, NJ). Forskolin, MDL 12330A, H89, KG-501, C646, TPA, 1,2-dioctanoyl-<italic>sn</italic>-glycerol (DiC8), calphostin C, U73122, 2-APB, Bay K8644, KN62, nicardipine, calmidazolium, cyclosporin A, INCA-6 and 11R-VIVIT were obtained from Merck (Rahway, NJ) while 8-bromo-cAMP (8Br.cAMP), N<sup>6</sup>-benxoyl-cAMP (6-Bnz-cAMP), 8-pCPT-2&#x2019;-O-Me-cAMP-AM (pCPT-O-Me-cAMP) and SGC-CBP30 were purchased from Tocris Bioscience (Bristol, UK). Except for the native GnRHs and sGnRH-A, which were dissolved in double-distilled deionized water, the other test substances were dissolved in DMSO and stored frozen at -80&#xb0;C in small aliquots. On the day for drug testing in cell culture, frozen stocks of test substances were thawed on ice and diluted with prewarmed culture medium to target concentrations 15 min prior to drug administration. The final dilutions of DMSO were always &#x2264; 0.1% and did not alter PRL release and transcript expression based on our previous validation in carp pituitary cells (<xref ref-type="bibr" rid="B55">55</xref>).</p>
</sec>
<sec id="s2_2">
<label>2.2</label>
<title>Static incubation of grass carp pituitary cells</title>
<p>Grass carp pituitary cells prepared with trypsin/DNase II digestion method (<xref ref-type="bibr" rid="B56">56</xref>) were seeded in poly-D-lysine coated 24-well plates at a density of ~2.5 &#xd7; 10<sup>6</sup> cells/well and incubated for 18 hr at 28&#xb0;C under 5% CO<sub>2</sub> and saturated humidity in carp MEM (MEM with 26 mM NaHCO<sub>3</sub>, 25 mM HEPES and 1% antibiotic-antimycotic; pH 7.7) with 5% FBS to allow for recovery from enzyme digestion. After that, culture medium was replaced with serum-free carp MEM with 0.1% BSA containing (i) GnRHs/sGnRH-A for the duration/doses as indicated, (ii) pharmacological activators targeting different pathways, or (iii) sGnRH-A with co-treatment of pharmacological inhibitors for different signalling targets. For the doses of pharmacological tools used, they were selected based on our previous reports using the same activators/inhibitors to probe the respective pathways in pituitary cells of fish origin, e.g. in goldfish (<xref ref-type="bibr" rid="B26">26</xref> &amp; references within) and grass carp (<xref ref-type="bibr" rid="B57">57</xref>, <xref ref-type="bibr" rid="B58">58</xref>), or using the effective dose range and ED<sub>50</sub>/IC<sub>50</sub> reported for the respective drugs provided by the suppliers as a reference. After treatment, culture medium was harvested for monitoring PRL secretion using RIA with antiserum for carp PRL (<xref ref-type="bibr" rid="B59">59</xref>). For cell content and total production of PRL, pituitary cells were lysed in double-distilled deionized water with 3 cycles of freezing and thawing followed by sonication in a digital ultrasonic bath. After centrifugation at 10,000 &#xd7;<italic>g</italic> for 15 min at 4&#xb0;C for sample clearing, the lysate obtained was used for RIA to determine PRL cell content and total production of PRL was defined as the sum total of PRL release and PRL cell content in the same sample. For PRL mRNA expression, total RNA was isolated from pituitary cells using TRIzol (Thermo Fisher, Waltham, MA), reversely transcribed by Superscript II (Thermo Fisher) and subjected to real-time PCR for PRL mRNA measurement. In selected experiments, parallel quantitation of CaM mRNA expression using a similar approach was also conducted. In both cases, real-time PCR was performed with a QuantiTect RT-PCR Kit (Qiagen, Hilden, Germany) in RotorGene-Q qPCR System (Qiagen) with primers and PCR conditions as described in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S1</bold>
</xref>. The authenticity of PCR products was routinely confirmed after real-time PCR assays by melting curve analysis (with <italic>Tm</italic> at 93.6&#xb0;C for PRL and 89.8&#xb0;C for CaM) and serial dilutions of plasmid DNA carrying the ORF of target gene were used as the standards for data calibration. In these studies, real-time PCR for 18S RNA was also conducted to serve as the internal control.</p>
</sec>
<sec id="s2_3">
<label>2.3</label>
<title>GnRHR expression in grass carp lactotrophs</title>
<p>In grass carp, four types of GnRHR, namely GnRHR<sub>1&#x2013;4</sub>, have been identified in the brain (<xref ref-type="bibr" rid="B35">35</xref>). To study GnRHR<sub>1&#x2013;4</sub> expression in the hypothalamo-pituitary axis, RT-PCR was conducted in total RNA prepared from the carp hypothalamus, pituitary and freshly dispersed pituitary cells. Similar to real-time PCR, RNA samples isolated with TRIzol were reversely transcribed and subjected to PCR with primers for GnRHR<sub>1&#x2013;4</sub> respectively using the PCR conditions described in <xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Table S2</bold>
</xref>. To confirm GnRHR expression in lactotrophs, RT-PCR was also performed in immuno-identified lactotrophs isolated by Laser Capture Microdissection (LCM) (<xref ref-type="bibr" rid="B60">60</xref>). Briefly, immunocytochemical (ICC) staining with an antiserum for carp PRL using the ABC technique (<xref ref-type="bibr" rid="B56">56</xref>) was conducted in cytospin preparation of carp pituitary cells seeded at a density of ~5 &#xd7; 10<sup>4</sup> cells/slide and lactotrophs with distinct signal of PRL immunoreactivity were isolated by LCM with infra-red laser (7.5 &#x3bc;m in diameter) set at 65 mW and pulse duration at 1.2 ms using a PixCell Cell Isolation Workstation (Arcturus, Mountain View, CA). A total of 250 lactotrophs captured on Capsure HS caps (Arcturus) was dissolved in TRIzol for total RNA isolation. After DNase I digestion, half of the RNA sample was reversely transcribed with Superscript II (as &#x201c;+RT&#x201d; group) followed by PCR detection of GnRHR<sub>1&#x2013;4</sub> as described in preceding section but with the cycle no increased to 55 cycles. To check for possible contamination of genomic DNA, the remaining half of the RNA sample was subjected to the same procedures in the absence of Superscript II (as &#x201c;-RT&#x201d; group). In our study for GnRHR expression, parallel PCR for &#x3b2; actin was also conducted to serve as the internal control and the PCR products obtained for the respective targets were resolved in 1% agarose gel and visualized with ethidium bromide staining.</p>
</sec>
<sec id="s2_4">
<label>2.4</label>
<title>cAMP and Ca<sup>2+</sup> signals in pituitary cells prepared from rostral pars distalis</title>
<p>Since the rostral pars distalis (RPD) was previously shown to be the region in carp pituitary with cells composed mostly of lactotrophs (<xref ref-type="bibr" rid="B56">56</xref>), the RPD of carp pituitaries was manually dissected under a stereo-microscope and used for pituitary cell preparation. The cells obtained (referred to as the &#x201c;RPD cells&#x201d;) were seeded at a density of ~3 &#xd7; 10<sup>6</sup> cells/2 ml/dish in poly-D-lysine coated 35 mm petri dishes (Corning, NY). After 18-hr recovery at 28&#xb0;C in carp MEM with 5% FBS, culture medium in individual dishes was replaced with 0.9 ml HEPES-buffered HBSS solution (Hanks Balanced Salt Solution with 26 mM NaHCO<sub>3</sub>, 25 mM HEPES and 1% antibiotic-antimycotic; pH 7.7) with 0.1% BSA and 0.1 mM IBMX. After a brief incubation for 10 min, treatment was initiated by adding 0.1 ml of 10&#xd7; stock of GnRH prepared in the same medium. RPD cells were then incubated with GnRH for another 15 min and the culture medium was harvested for measurement of cAMP release. Meanwhile, the cell content of cAMP was extracted from the remaining cells with 1 ml ice-cold absolute ethanol. The samples collected were then freeze-dried in a lyophilizer and stored at -20&#xb0;C until their cAMP content measured with a BioTrak [<sup>125</sup> I] cAMP RIA Kit (Amersham, UK). In this experiment, total production of cAMP was defined as the sum total of cAMP cell content and cAMP release in the same sample during the test period.</p>
<p>To monitor Ca<sup>2+</sup> signals in carp lactotrophs, Ca<sup>2+</sup> florescence imaging was conducted in RPD cells seeded at a density of 1 &#xd7; 10<sup>4</sup> cells/coverslip on poly-D-lysine precoated Cell-Locate Cover Glass (Thermo Fisher) after 18-hr recovery at 28&#xb0;C in carp MEM with 5% FBS as described previously (<xref ref-type="bibr" rid="B55">55</xref>). Prior to Ca<sup>2+</sup> imaging, PRD cells were preloaded with the Ca<sup>2+</sup>-sensitive dye Fura-2/AM (5 &#x3bc;M; Molecular Probes, Eugene, OR) for 45 min in Krebs-Ringer Buffer (120 mM NaCl, 4.7 mM KCl, 0.7 mM MgSO<sub>4</sub>, 1.2 mM CaCl<sub>2</sub>, 10 mM glucose and 15 mM HEPES; pH 7.4). After that, the cells were rinsed and incubated at room temperature with Krebs-Ringer Buffer for 15 min to allow for de-esterification of Fura-2/AM in RPD cells. Detection of intracellular Ca<sup>2+</sup> ([Ca<sup>2+</sup>]i) signals was conducted at room temperature with epifluorescence microscope linked with a PTI DeltaScan Ca<sup>2+</sup> Imaging System (Photon Technology, West Sussex, UK). Emission was monitored at 510 nm with excitation wavelength alternating between 340 nm and 380 nm at 1-sec interval. During the process, test substances were applied gently by hand pipetting into the imaging chamber with RPD cells attached to Cell-Locate coverslip. For <italic>post facto</italic> identification of lactotrophs with Ca<sup>2+</sup> responses, bright field picture of RPD cells was captured followed by Ca<sup>2+</sup> imaging before and after drug testing. After that, ICC staining of RPD cells with PRL antiserum was used to locate the lactotrophs and matched with the cells with Ca<sup>2+</sup> responses grid by grid according to the numeric labels of the grid matrix photo-etched on the Cell-Locate coverslip.</p>
</sec>
<sec id="s2_5">
<label>2.5</label>
<title>Western blot for transcription factors and CaM expressed in RPD cells</title>
<p>Similar to the preceding study for cAMP signals, RPD cells were cultured in 35 mm dishes at a seeding density of ~6 &#xd7; 10<sup>6</sup> cells/2 ml/dish and incubated with carp MEM containing test substances for the duration as indicated in individual experiments. After that, the cells were rinsed with PBS and lysed in 250 &#x3bc;l RIPA lysis buffer (50 mM Tris-HCl, 1% Nonidet-P40, 0.25% sodium deoxycholate, 1 mM EDTA and 150 mM NaCl) supplemented with 1&#xd7; protease and phosphatase inhibitor cocktail (Roche, Basel, Switzerland). The resulting lysate was cleared by centrifugation at 10,000 &#xd7;<italic>g</italic> at 4&#xb0;C for 10 min and the supernatant obtained was resolved in 12% gel by SDS-PAGE followed by transblotting onto a nitrocellulose membrane (Thermo Fischer) using a TE77 Semi-dry Electroblotting Unit (Asmersham). After that, the membrane with protein samples was used for Western blot as described previously (<xref ref-type="bibr" rid="B60">60</xref>) using the antibodies for phosphorylated CREB (1:1300, Santa Cruz), total CREB (1:1000, Santa Cruz), c-Fos (1:2000, Santa Cruz), c-Jun (1:1000, Merck), CaM (1:1000, Sigma-Aldrich), and phosphorylated NFAT<sub>1</sub> (also called NFATC2) and NFAT<sub>2</sub> (also called NFATC1) (1:1000, Thermal Fischer), respectively. Chemiluminescence signals for target proteins were detected with Immobilon Western Chemiluminescent Substrate (Sigma) and visualized using a ChemiDoc Imaging System (Bio-Rad, Hercules, CA). In these studies, parallel blotting of &#x3b2; actin using an Actin Ab-I Kit (Oncogene, Cambridge, MA) was also conducted to serve as the loading control. In the experiment for NFAT phosphorylation, the antibodies for total protein of NFAT<sub>1</sub> and NFAT<sub>2</sub> from the same company were found to be not useful in carp model and parallel blotting for tubulin was used as the internal control.</p>
</sec>
<sec id="s2_6">
<label>2.6</label>
<title>Immunofluorescence imaging for nuclear translocation of CREB</title>
<p>RPD cells were seeded at a density of ~1.3 &#xd7; 10<sup>6</sup> cells/0.3 ml/chamber in poly-D-lysine coated &#x3bc;-Slide 8-Well Chambered Coverslip (ibidi GmbH, Grafelfing, Germany) and incubated for 18 hr with carp MEM containing 5% FBS at 28&#xb0;C under 5% CO<sub>2</sub> for recovery after cell dispersion. After that, the culture medium was gently aspired and replaced with carp MEM with 0.1% BSA containing GnRH or forskolin (as positive control). Following a 30-min incubation with test substances, the cells were fixed in 4% paraformaldehyde, rinsed with PBS, subjected to endogenous peroxidase inactivation with 3% H<sub>2</sub>O<sub>2</sub> and background reduction using blocking reagent (Roche), and incubated overnight at 4&#xb0;C with the antibody for total CREB (1:1000, Santa Cruz). On the next day, the cells were washed 3 times with TNT buffer (0.1 M Tris-HCl, 0.15 NaCl and 0.05% Tween 20; pH 7.5), incubated for 30 min at room temperature with GAR-HRP (1: 200; Biotium Inc., Fremont, CA), and exposed to CF488A-TSA (1:400; Biotium Inc.) for tyramide signal amplification for 10 min followed by DAPI staining. For qualitative assessment of CREB responses, fluorescence images of CREB related to DAPI signals in the nuclei were captured using LSM 980 Confocal Microscopy System (Carl Zeiss, Jem, Germany). For quantitation of CREB nuclear translocation, similar fluorescence images were captured with BioTek Cytation-1 Cell Imaging Multimode Reader (Agilent, Santa Clara, CA). Using the images of CREB and DAPI signals in the same visual field, the total amount of CREB fluorescence in the nuclei of RPD cells and percentage of RPD cells with nuclear translocation of CREB were determined by the Gen 5 Image Analysis Software (Agilent) using a filter mask for fluorescence detection in the nucleus constructed based on the DAPI signals.</p>
</sec>
<sec id="s2_7">
<label>2.7</label>
<title>Data normalization and statistical analysis</title>
<p>For PRL secretion and protein expression in pituitary cells, the raw data from RIA expressed as ng/ml for PRL released into culture medium and ng/&#xd7;10<sup>6</sup> cells for PRL cell content and total production were used directly for statistical analysis. For transcript expression of PRL and CaM, the raw data from real-time PCR expressed as femtomole transcript detected per &#xd7;10<sup>6</sup> cells were deduced from the standard curve constructed by serial dilutions of plasmid DNA with ORF of the target gene using data calibration under unsupervised mode with RotorGene-Q software 1.7 (Qiagen). The data obtained were normalized with 18S RNA detected in the same sample and transformed as a percentage of the mean value in the control group (&#x201c;%Ctrl&#x201d;). For dose-dependence of GnRH treatment on PRL secretion and PRL mRNA expression, the maximal responses and ED<sub>50</sub> values of the respective dose-response curves were deduced by four-parameter logistic regression using Prism software (GraphPad, Boston, MA). For CREB fluorescence signal in the nucleus, the raw data in terms of relative fluorescence unit (as &#x201c;RFU&#x201d;) were normalized with DAPI signals detected in the same visual field. Data presented (Mean &#xb1; SEM, N = 3 - 4) were analysed with one-way ANOVA followed by Newman-Keuls test for dose-dependence studies and regular drug testing with a fixed duration of treatment or two-way ANOVA followed by Bonferroni test for time-course studies using Prism. Differences between experimental groups were considered as significant at <italic>p</italic> &lt; 0.05.</p>
</sec>
</sec>
<sec id="s3" sec-type="results">
<label>3</label>
<title>Results</title>
<sec id="s3_1">
<label>3.1</label>
<title>GnRHR expression in carp lactotrophs</title>
<p>Recently, grass carp was shown to have four GnRHRs, namely GnRHR<sub>1&#x2013;4</sub>, expressed in a tissue-specific manner (<xref ref-type="bibr" rid="B35">35</xref>). To test for GnRHR<sub>1&#x2013;4</sub> expression in the hypothalamo-pituitary axis, RT-PCR was performed in the hypothalamus, pituitary and pituitary cells of grass carp. As shown in <xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1A</bold>
</xref>, transcript signals for the four types of GnRHR were detected in the hypothalamus and pituitary. Interestingly, the results based on pituitary cells were at variance with that of the whole pituitary. In this case, GnRHR<sub>3</sub> expression was not apparent in pituitary cells despite the PCR signals for GnRHR<sub>1, 2 &amp; 4</sub> could still be noted. To confirm that lactotrophs can serve as a regulatory target for GnRH, RT-PCR for GnRHR<sub>1&#x2013;4</sub> was also examined in pituitary cells isolated by LCM with positive staining of PRL immunoreactivity (<xref ref-type="fig" rid="f1">
<bold>Figure&#xa0;1B</bold>
</xref>). Unlike the results for mixed populations of pituitary cells, only the PCR signal for GnRHR<sub>4</sub> could be detected in immuno-identified lactotrophs captured by LCM.</p>
<fig id="f1" position="float">
<label>Figure&#xa0;1</label>
<caption>
<p>GnRHR expression in carp lactotrophs. <bold>(A)</bold> GnRHR expression in the hypothalamo-pituitary axis of grass carp. Using RT-PCR with primers for carp GnRHR<sub>1&#x2013;4</sub>, the expression of the 4 isoforms of GnRHR in grass carp was examined in the hypothalamus, pituitary, and freshly dispersed pituitary cells. <bold>(B)</bold> GnRHR expression in immuno-identified lactotrophs (PRL cells) in grass carp. Pituitary cells with PRL signals as revealed by ICC staining using PRL antiserum were isolated using LCM and subjected to RT-PCR for GnRHR<sub>1&#x2013;4</sub> with (+RT) or without reverse transcription (-RT) during the preparation of RT samples. RT-PCR using mixed populations of pituitary cells was used as a positive control for our study (except for GnRHR<sub>3</sub>, which was used as a negative control). Parallel PCR for &#x3b2; actin expression was routinely conducted to serve as an internal control for the quality of RNA prepared.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g001.tif"/>
</fig>
</sec>
<sec id="s3_2">
<label>3.2</label>
<title>GnRH-induced PRL release and gene expression in carp pituitary cells</title>
<p>To test the pituitary action of GnRH on PRL regulation, static incubation of pituitary cells prepared from carp pituitaries was conducted with sGnRH-A treatment. The &#x201c;superactive analog&#x201d; sGnRH-A was used in our study as it can bind fish GnRHR with high affinity (<xref ref-type="bibr" rid="B61">61</xref>) and is commonly used in induced spawning for commercial fish (<xref ref-type="bibr" rid="B62">62</xref>). In carp pituitary cells, sGnRH-A (1 &#x3bc;M) could elevate PRL release and PRL mRNA levels in a time-related fashion up to 48 hr (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2A</bold>
</xref>). By fixing the duration of treatment at 48 hr, increasing concentrations of sGnRH-A (1&#x2013;1000 nM) were found to induce PRL secretion and PRL gene expression in a dose-dependent manner (<xref ref-type="fig" rid="f2">
<bold>Figure&#xa0;2B</bold>
</xref>). The dose dependence of PRL responses caused by sGnRH-A could also be mimicked by parallel treatment with increasing levels (1&#x2013;1000 nM) of GnRH2 and GnRH3, respectively (<xref ref-type="fig" rid="f2">
<bold>Figures&#xa0;2C, D</bold>
</xref>). Although the stimulatory effects of GnRH2 and GnRH3 on PRL secretion were comparable to sGnRH-A in terms of the maximal responses and ED<sub>50</sub> values, the corresponding responses for PRL mRNA were quite different. In this case, the potency (reflected by ED<sub>50</sub> values) and efficacy (revealed by maximal responses) for PRL gene expression induced by sGnRH-A and GnRH3 were notably higher than those of GnRH2. Consistent with the results on PRL mRNA expression, increasing levels (1&#x2013;1000 nM) of sGnRH-A, GnRH2 and GnRH3 were also effective in elevating PRL cell content ant total production along with their stimulatory effects on PRL release (<xref ref-type="fig" rid="f3">
<bold>Figures&#xa0;3A&#x2013;C</bold>
</xref>).</p>
<fig id="f2" position="float">
<label>Figure&#xa0;2</label>
<caption>
<p>Effects of GnRH on PRL release and PRL mRNA expression in grass carp pituitary cells. <bold>(A)</bold> Time course and <bold>(B)</bold> dose dependence of sGnRH-A on PRL secretion and gene expression. Pituitary cells were exposed to sGnRH-A (1 &#x3bc;M) for the duration as indicated for the time course study or treated for 48 hr with increasing levels of sGnRH-A (1&#x2013;1000 nM) for the dose-dependence study. Comparison of the potency and efficacy of sGnRH-A, GnRH2 and GnRH3 on <bold>(C)</bold> PRL release and <bold>(D)</bold> PRL mRNA expression at pituitary cell level. Pituitary cells were treated for 48 hr with increasing doses (1&#x2013;1000 nM) of sGnRH-A, GnRH2 and GnRH3, respectively. The ED<sub>50</sub> (for potency) and maximal responses (for efficacy) for individual dose-response curves were deduced by four-parameter logistic regression using GraphPad Prism. Experimental groups denoted by different letters represent a significant difference at <italic>p</italic> &lt; 0.05 (one-way ANOVA followed by Newman-Keuls test for dose-dependence studies and two-way ANOVA followed by Bonferroni test for time-course study).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g002.tif"/>
</fig>
<fig id="f3" position="float">
<label>Figure&#xa0;3</label>
<caption>
<p>Effects of GnRH on PRL release, cell content and total production in grass carp pituitary cells. Pituitary cells were treated for 48 hr with increasing doses (1&#x2013;1000 nM) of <bold>(A)</bold> sGnRH-A, <bold>(B)</bold> GnRH2 and <bold>(C)</bold> GnRH3, respectively. Total production of PRL was defined as the sum total of PRL cell content and PRL released into culture medium in the same sample. Experimental groups marked by different letters denote a significant difference at <italic>p</italic> &lt; 0.05 (one-way ANOVA followed by Newman-Keuls test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g003.tif"/>
</fig>
</sec>
<sec id="s3_3">
<label>3.3</label>
<title>AC/cAMP/PKA pathway in GnRH-induced PRL release and gene expression</title>
<p>Given that cAMP involvement in GnRH-induced LH secretion and gene expression has been reported in fish models (<xref ref-type="bibr" rid="B63">63</xref>), the functional role of cAMP/PKA pathway in PRL regulation was examined in carp pituitary cells. Similar to the results of GnRH treatment, a 48-hr incubation with the adenylate cyclase (AC) activator forskolin (0.1&#x2013;10 &#x3bc;M, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4A</bold>
</xref>) and membrane-permeant cAMP analog 8Br.cAMP (10&#x2013;1000 &#x3bc;M, <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4B</bold>
</xref>) were both effective in increasing PRL release and PRL mRNA levels in a dose-dependent manner. Since PKA and Epac are known to be the downstream effectors for cAMP, their possible involvement in PRL regulation was also tested. As shown in <xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4C</bold>
</xref>, PRL secretion and gene expression could be elevated by the PKA-specific cAMP analog 6-Bnz-cAMP (1 mM) but not the Epac-specific cAMP analog pCPT-O-Me-cAMP (1 mM). In carp pituitary cells, the stimulatory effects of forskolin (10 &#x3bc;M) on PRL secretion and transcript expression could also be reduced/totally blocked by co-treatment with the AC inhibitor MDL 12330A (20 &#x3bc;M) or PKA inactivator H89 (20 &#x3bc;M) (<xref ref-type="fig" rid="f4">
<bold>Figure&#xa0;4D</bold>
</xref>).</p>
<fig id="f4" position="float">
<label>Figure&#xa0;4</label>
<caption>
<p>Functional role of cAMP/PKA-dependent pathway on PRL release and PRL mRNA expression in carp pituitary cells. Increasing cAMP at cellular level using <bold>(A)</bold> the AC activator forskolin (0.1&#x2013;10 &#x3bc;M) or <bold>(B)</bold> cell-permeant cAMP analog 8Br.cAMP (10&#x2013;1000 &#x3bc;M) on PRL release and gene expression. <bold>(C)</bold> Effects of the PKA-specific cAMP analog 6-Bnz-cAMP (1 mM) and Epac-specific cAMP analog pCPT-O-Me-cAMP (1 mM) on PRL secretion and gene expression. <bold>(D)</bold> Co-treatment with the AC inhibitor MDL 12330A (20 &#x3bc;M) or PKA blocker H89 (20 &#x3bc;M) on PRL secretion and gene expression induced by forskolin (10 &#x3bc;M). In these experiments, the duration of drug treatment was fixed at 48 hr. Experimental groups denoted by difference letters represent a significant difference at <italic>p</italic> &lt; 0.05 (one-way ANOVA followed by Newman-Keuls test).</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g004.tif"/>
</fig>
<p>In pituitary cells prepared from whole pituitaries (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, upper panel) or RPD cells prepared from the RPD region of carp pituitaries (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5A</bold>
</xref>, lower panel), short-term incubation for 15 min with increasing doses of sGnRH-A (10&#x2013;1000 nM) was found to up-regulate cAMP release, cAMP cell content and total production of cAMP in a dose-dependent manner. Notable responses for cAMP secretion and cAMP production were also observed with similar treatment of forskolin (10 &#x3bc;M), which was used as a positive control in our study. In agreement with protein phosphorylation by PKA via cAMP signals, similar treatment with sGnRH-A (1 &#x3bc;M) could induce a rapid but transient rise in CREB phosphorylation in RPD cells with a peak response at 10 min (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, upper panel). In the same experiment, CREB phosphorylation also occurred with forskolin treatment (10 &#x3bc;M) and the response was sustained up to 30 min (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5B</bold>
</xref>, lower panel). Using fluorescence imaging after ICC staining, a 30-min incubation with sGnRH-A (1&#x3bc;M) and forskolin (10 &#x3bc;M) were both effective in triggering a notable rise in nuclear translocation of CREB in RPD cells (<xref ref-type="fig" rid="f6">
<bold>Figure&#xa0;6</bold>
</xref>). The results obtained were also consistent with parallel fluorescence quantitation and cell counting using a Cytation-1 imaging station, in which CREB signals detected in the nucleus and percentage of RPD cells with nuclear translocation of CREB were found to be significantly elevated by sGnRH-A and forskolin in the same study (<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Figure S2</bold>
</xref>). In parallel studies with pituitary cells prepared from whole pituitaries, PRL release and PRL mRNA expression induced by sGnRH-A (1 &#x3bc;M) could be totally negated by blocking G<sub>s</sub> activation with the G<sub>s</sub> inhibitor melittin (100 nM). Similar to preceding study with forskolin, the PRL responses caused by sGnRH-A (1 &#x3bc;M) could be reduced/abolished by co-treatment with the AC inhibitor MDL 12330A (20 &#x3bc;M) or PKA inhibitor H89 (20 &#x3bc;M) (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5C</bold>
</xref>). Of note, PRL gene expression induced by sGnRH-A (1 &#x3bc;M) were also blocked by similar treatment with the CREB inhibitor KG-501 (10 &#x3bc;M), CREB:CBP interaction blocker SGC-CBP30 (10 &#x3bc;M) or histone acetyltransferase (HAT) inactivator C646 (0.1 &#x3bc;M). Interestingly, these inhibitors were not effective in altering the parallel responses for PRL secretion (<xref ref-type="fig" rid="f5">
<bold>Figure&#xa0;5D</bold>
</xref>).</p>
<fig id="f5" position="float">
<label>Figure&#xa0;5</label>
<caption>
<p>Functional role of cAMP/PKA-dependent pathway on GnRH-induced PRL secretion and PRL mRNA expression in carp pituitary cells. <bold>(A)</bold> GnRH treatment on cAMP production in carp RPD cells. RPD cells prepared from the RPD of carp pituitaries were treated for 15 min with sGnRH-A (10&#x2013;1000 nM) with parallel monitoring of cAMP release and cAMP cell content. cAMP production was defined as the sum of cAMP cell content and cAMP released into culture medium in the same sample. Similar treatment with sGnRH-A was also performed in pituitary cells prepared from whole pituitaries as a parallel control. In the same study, forskolin treatment (10 &#x3bc;M) was used as a positive control for cAMP production at cellular level. <bold>(B)</bold> GnRH treatment on CREB phosphorylation in carp RPD cells. RPD cells were exposed to sGnRH-A (1 &#x3bc;M) up to 30 min followed by Western blot using the antibodies for phosphorylated form (&#x201c;P&#x201d;-form) and total protein (&#x201c;T&#x201d;-form) of CREB. Forskolin treatment (10 &#x3bc;M) was used as a positive control and parallel Western blot for &#x3b2; actin was used as the loading control for individual experiments. Blocking <bold>(C)</bold> cAMP/PKA and <bold>(D)</bold> CREB/CBP signalling on GnRH-induced PRL secretion and gene expression in carp pituitary cells. Pituitary cells were incubated with sGnRH-A (1 &#x3bc;M) for 48 hr with/without the co-treatment the G<sub>s</sub> inhibitor melittin (100 nM), AC repressor MDL 12330A (20 &#x3bc;M), PKA blocker H89 (20 &#x3bc;M), CREB inactivator KG-501 (10 &#x3bc;M), CREB: CBP interaction inhibitor SGC-CBP30 (10 &#x3bc;M), and HAT blocker C646 (0.1 &#x3bc;M), respectively. Groups denoted by different letters represent a significant difference at <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g005.tif"/>
</fig>
<fig id="f6" position="float">
<label>Figure&#xa0;6</label>
<caption>
<p>Effect of GnRH treatment on CREB nuclear translocation in carp RPD cells. RPD cells cultured in &#x3bc;-Slide 8-chambered coverslips were treated for 30 min with <bold>(A)</bold> culture medium (as control group), <bold>(B)</bold> sGnRH-A (1 &#x3bc;M), or <bold>(C)</bold> forskolin (10 &#x3bc;M, as a positive control) followed by immunofluorescence staining with the antibody for total CREB. Using confocal imaging, CREB signals revealed by CF488A fluorescence and DAPI signals (to define the nuclei of RPD cells) were captured and these images were merged with the Zen lite 2.1 software to highlight the nuclei with notable signals of nuclear translocation of CREB after drug treatment.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g006.tif"/>
</fig>
</sec>
<sec id="s3_4">
<label>3.4</label>
<title>PLC/IP<sub>3</sub>/PKC pathway in GnRH-induced PRL release and gene expression</title>
<p>Given that the PLC/IP<sub>3</sub>/PKC pathway is well-documented to be a major component of GnRH signalling for LH secretion and gene expression in mammalian models (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>), its involvement in PRL regulation by GnRH was also tested in carp pituitary cells. As shown in <xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7A, B</bold>
</xref>, a 48-hr incubation with increasing levels of the membrane-permeant DAG analog DiC8 (1&#x2013;100 &#x3bc;M) or PKC activator TPA (10&#x2013;1000 nM) was effective in elevating PRL release and PRL mRNA levels in a dose-related fashion. Furthermore, the PRL responses induced by TPA (1 &#x3bc;M) and DiC8 (100 &#x3bc;M) could be reduced/negated by co-treatment with the PKC inhibitor calphostin C (1 &#x3bc;M, <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7C</bold>
</xref>). In parallel studies with sGnRH-A as the stimulant (<xref ref-type="fig" rid="f7">
<bold>Figures&#xa0;7D, E</bold>
</xref>), co-treatment with the G<sub>q/11</sub> blocker YM254890 (1 &#x3bc;M), PLC blocker U73122 (5 &#x3bc;M) or PKC inhibitor calphostin C (1 &#x3bc;M) was found to reduce PRL release induced by sGnRH-A (1 &#x3bc;M). Inhibiting G<sub>q/11</sub> with YM254890 (1 &#x3bc;M) was also effective in blocking the PRL transcript response caused by sGnRH-A (1 &#x3bc;M) but no major effect could be noted for the corresponding stimulation on PRL gene expression with U73122 (5 &#x3bc;M) or calphostin C treatment (1 &#x3bc;M). In the same study, co-treatment with the IP<sub>3</sub> channel inhibitor 2-APB (50 &#x3bc;M) did not alter sGnRH-A stimulation on PRL secretion and gene expression (<xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7E</bold>
</xref>), and the same was true with co-treatment of the IP<sub>3</sub> antagonist xestospongin C (3 mM) (data not shown). To examine the possible role of transcription factors working downstream of the PLC/PKC pathway in PRL regulation by GnRH, Western blot for c-Fos and c-Jun was conducted in RPD cells with GnRH stimulation. As shown in <xref ref-type="fig" rid="f7">
<bold>Figure&#xa0;7F</bold>
</xref>, notable changes for c-Fos and c-Jun expression in RPD cells were not apparent with sGnRH-A treatment (1 &#x3bc;M) up to 30 min.</p>
<fig id="f7" position="float">
<label>Figure&#xa0;7</label>
<caption>
<p>Functional role of PLC/PKC-dependent pathway on PRL release and PRL mRNA expression in carp pituitary cells. To test the effect of PKC activation on PRL release and gene expression, pituitary cells were treated for 48 hr with <bold>(A)</bold> the DAG analog DiC8 (1&#x2013;100 &#x3bc;M) or <bold>(B)</bold> PKC activator TPA (10&#x2013;1000 nM). <bold>(C)</bold> PKC involvement in the PRL responses caused by TPA (1 &#x3bc;M) and DiC8 (100 &#x3bc;M) were further confirmed with co-treatment of the PKC inhibitor calphostin C (1 &#x3bc;M). In parallel experiments, the functional role of <bold>(D)</bold> G<sub>q/11</sub> coupling with PLC and <bold>(E)</bold> IP<sub>3</sub> and PKC working downstream of PLC in GnRH-induced PRL release and PRL mRNA expression was also examined. In this case, pituitary cells were exposed to sGnRH-A (1 &#x3bc;M) for 48 hr in the presence of the G<sub>q/11</sub> blocker YM254890 (1 &#x3bc;M), PLC repressor U73122 (5 &#x3bc;M), PKC inhibitor calphostin C (1 &#x3bc;M) and IP<sub>3</sub> channel inactivator 2-APB (50 &#x3bc;M), respectively. <bold>(F)</bold> Possible link of AP-1 transcription factors with GnRH treatment in carp RPD cells. RPD cells were challenged with sGnRH-A (1 &#x3bc;M) up to 30 min followed by Western blot using the antibodies for c-Fos and c-Jun, respectively. Western blot for &#x3b2; actin was also conducted to serve as a loading control. For PRL secretion and gene expression in carp pituitary cells, experimental groups denoted by different letters represent a significant difference at <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g007.tif"/>
</fig>
</sec>
<sec id="s3_5">
<label>3.5</label>
<title>Ca<sup>2+</sup>/CaM-dependent pathway in GnRH-induced PRL release and gene expression</title>
<p>To shed light on the role of Ca<sup>2+</sup>/CaM-dependent pathway in PRL regulation by GnRH, RPD cells were preloaded with the Ca<sup>2+</sup>-sensitive dye Fura-2 and used for single-cell Ca<sup>2+</sup> imaging with GnRH treatment. As a first step for system validation, RPD cells with dye loading were challenged with the VSCC activator BayK 8644. As shown in <xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8A</bold>
</xref>, a rapid rise in [Ca<sup>2+</sup>]i signals were noted after BayK 8644 treatment (10 &#x3bc;M) and this Ca<sup>2+</sup> response could be negated by the L-type VSCC blocker nicardipine (5 &#x3bc;M). In parallel studies with pituitary cells prepared from whole pituitaries, BayK 8644 (0.1&#x2013;10 &#x3bc;M) was also effective in elevating PRL release and PRL mRNA levels in a dose-dependent manner (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8B</bold>
</xref>) and these stimulatory effects were ablated by co-treatment with the L-type VSCC blocker nicardipine (5 &#x3bc;M) or calmodulin (CaM) antagonist calmidazolium (1 &#x3bc;M) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8C</bold>
</xref>). Of note, co-treatment with the Ca<sup>2+</sup>/CaM-dependent protein kinase-II (CaMK-II) inhibitor KN62 (5 &#x3bc;M) could abolish the PRL-releasing effect of BayK 8644 (5 &#x3bc;M) but not the corresponding induction on PRL gene expression whereas the opposite was true for parallel co-treatment with the calcineurin (CaN) inactivator cyclosporin A (100 nM) (<xref ref-type="fig" rid="f8">
<bold>Figure&#xa0;8D</bold>
</xref>).</p>
<fig id="f8" position="float">
<label>Figure&#xa0;8</label>
<caption>
<p>Functional role of Ca<sup>2+</sup>/CaM-dependent pathway on PRL release and PRL mRNA expression in carp pituitary cells. <bold>(A)</bold> Activation of L-type VSCC on Ca<sup>2+</sup> signals detected in carp RPD cells. RPD cells preloaded with the Ca<sup>2+</sup>-sensitive dye Fura-2 were exposed to the VSCC activator Bay K8644 (10 &#x3bc;M) in the presence or absence of the L-type VSCC blocker nicardipine (5 &#x3bc;M). During the process, the kinetics of Ca<sup>2+</sup> response was monitored based on the ratio of fluorescence output with excitation wavelength alternating between 340 nm and 380 nm (as &#x201c;F340/F380&#x201d;). In this experiment, the vehicle (Veh) used for solubilization of test substances was used as the control treatment. <bold>(B)</bold> VSCC activation in carp pituitary cells by increasing doses of Bay K8644 (0.1&#x2013;10 &#x3bc;M) on PRL release and PRL mRNA expression. <bold>(C)</bold> L-type VSCC blockade and CaM antagonism, or <bold>(D)</bold> CaMK-II and CaN inactivation on the PRL responses induced by Bay K8644. Carp pituitary cells were challenged with Bay K8644 (5 &#x3bc;M) for 48 hr with/without the co-treatment of the L-type VSCC blocker nicardipine (5 &#x3bc;M), CaM antagonist calmidazolium (1 &#x3bc;M), CaMK-II inhibitor KN62 (5 &#x3bc;M) or CaN inactivator cyclosporin A (100 nM). For PRL secretion and gene expression in carp pituitary cells, experimental groups denoted by different letters represent a significant difference at <italic>p</italic> &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g008.tif"/>
</fig>
<p>Similar to the Ca<sup>2+</sup> responses caused by BayK 8644, a rapid rise in [Ca<sup>2+</sup>]i could be induced by sGnRH-A (1 &#x3bc;M) in RPD cells and this Ca<sup>2+</sup> response was sensitive to the blockade by the L-type VSCC inhibitor nicardipine (5 &#x3bc;M) (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9A</bold>
</xref>). In RPD cells, the stimulatory effect of sGnRH-A on [Ca<sup>2+</sup>]i could be mimicked by parallel treatment with GnRH2 (1 &#x3bc;M) and GnRH3 (1 &#x3bc;M), respectively (<xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9B</bold>
</xref>). To confirm that the Ca<sup>2+</sup> responses indeed can occur in carp lactotrophs, <italic>post facto</italic> identification of lactotrophs by ICC staining with PRL antiserum was performed in RPD cells after Ca<sup>2+</sup> imaging with sGnRH-A (1 &#x3bc;M, <xref ref-type="fig" rid="f9">
<bold>Figure&#xa0;9C</bold>
</xref>). In this case, RPD cells with PRL immunoreactivity were shown to have notable Ca<sup>2+</sup> responses induced by sGnRH-A. The Ca<sup>2+</sup> signals were initiated in peripheral region underneath the plasma membrane, with the highest Ca<sup>2+</sup> rise occurred in the subplasmalemmal space and spread into the inner core of the responsive cells. As shown in <xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10A</bold>
</xref>, sGnRH-A (1 &#x3bc;M) consistently up-regulated PRL release and PRL mRNA levels in carp pituitary cells and these PRL responses could be reduced/abolished by the L-type VSCC blocker nicardipine (5 &#x3bc;M) or calmodulin (CaM) antagonist calmidazolium (1 &#x3bc;M). Similar to BayK 8644, PRL release induced by sGnRH-A (1 &#x3bc;M) could be blocked by the CaMK-II inhibitor KN62 (5 &#x3bc;M) but not the CaN inactivator cyclosporin A (100 nM). However, the corresponding rise in PRL mRNA level was reduced by cyclosporin A but not KN62 (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10B</bold>
</xref>). In parallel study to examine the possible involvement of the transcription factor NFAT working downstream of CaN, PRL transcript expression induced by sGnRH-A (1 &#x3bc;M) but not the corresponding rise in PRL secretion was found to be totally negated by co-treatment with the CaN:NFAT interaction inhibitor INCA-6 (5 &#x3bc;M) or NFAT nuclear translocation blocker 11R-VIVIT (1 &#x3bc;M) (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10C</bold>
</xref>). As revealed by Western blot, phosphorylated forms of NFAT<sub>1</sub> and NFAT<sub>2</sub> could be detected in RPD cells, probably with NFAT<sub>2</sub> as the major form. In the same study, treatment of RPD cells with sGnRH-A (1 &#x3bc;M) up to 30 min did not alter the phosphorylation status of NFAT<sub>1</sub> but induced a transient drop in NFAT<sub>2</sub> phosphorylation with a peak at 20 min (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10D</bold>
</xref>, left panel). Forskolin treatment (10 &#x3bc;M) also reduced NFAT<sub>2</sub> phosphorylation in RPD cells but with no effect on the corresponding signals of NFAT<sub>1</sub>, and this inhibitory action became quite noticeable in a time-dependent manner up to 30 min (<xref ref-type="fig" rid="f10">
<bold>Figure&#xa0;10D</bold>
</xref>, right panel).</p>
<fig id="f9" position="float">
<label>Figure&#xa0;9</label>
<caption>
<p>Ca<sup>2+</sup> responses induced by GnRH in carp lactotrophs. <bold>(A)</bold> Inactivating L-type VSCC on Ca<sup>2+</sup> signals induced by GnRH in carp RPD cells. RPD cells preloaded with Ca<sup>2+</sup>-sensitive dye Fura-2 were challenged with sGnRH-A (1 &#x3bc;M) in the presence or absence of the L-type VSCC blocker nicardipine (5 &#x3bc;M). <bold>(B)</bold> Effects of native GnRHs on Ca<sup>2+</sup> signals in carp RPD cells. Using a similar approach, RPD cells were also treated with the native GnRHs found in grass carp, namely GnRH2 (1 &#x3bc;M) and GnRH3 (1 &#x3bc;M), respectively. During the process, the kinetics of Ca<sup>2+</sup> response was monitored based on the ratio of fluorescence output with excitation wavelength alternating between 340 nm and 380 nm (as &#x201c;F340/F380&#x201d;). <bold>(C)</bold> Ca<sup>2+</sup> responses induced by GnRH in immuno-identified lactotrophs. RPD cells cultured on Cell-Locate coverslips were preloaded with Fura-2 and challenged with sGnRH-A (1 &#x3bc;M) with parallel fluorescence imaging of Ca<sup>2+</sup> responses. After that, <italic>post facto</italic> identification of lactotrophs (PRL cells) among the RPD cells attached on the same coverslip was conducted by ICC staining using the antiserum for carp PRL and mapped with the responsive cells with Ca<sup>2+</sup> rise induced by sGnRH-A. The <italic>post facto</italic> identification of lactotrophs with Ca<sup>2+</sup> responses was shown in the left panels while the kinetics of Ca<sup>2+</sup> responses observed in a representative PRL cell (PRD cell #17), with Ca<sup>2+</sup> images captured at time points as indicated by the letters in lower case) was shown in the right panels.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g009.tif"/>
</fig>
<fig id="f10" position="float">
<label>Figure&#xa0;10</label>
<caption>
<p>Functional role of Ca<sup>2+</sup>/CaM-dependent pathway on GnRH-induced PRL release and PRL mRNA expression in carp pituitary cells. <bold>(A)</bold> L-type VSCC blockade and CaM antagonism, <bold>(B)</bold> CaMK-II inhibition and CaN inactivation, and <bold>(C)</bold> interfering CaN: NFAT interaction or nuclear translocation of NFAT on PRL secretion and gene expression induced by GnRH. In these experiments, pituitary cells were treated with sGnRH-A (1 &#x3bc;M) for 48 hr in the presence or absence of the L-type VSCC inactivator nicardipine (5 &#x3bc;M), CaM antagonist calmidazolium (1 &#x3bc;M), CaMK-II inhibitor KN62 (5 &#x3bc;M), CaN repressor cyclosporin A (100 nM), CaN: NFAT interaction blocker INCA-6 (5 &#x3bc;M) and NFAT nuclear translocation inhibitor 11R-VIVIT (1 &#x3bc;M), respectively. Groups denoted by different letters represent a significant difference at p &lt; 0.05. <bold>(D)</bold> Effects of GnRH and forskolin treatment on NFAT dephosphorylation in carp RPD cells. RPD cells were challenged with sGnRH-A (1 &#x3bc;M) or forskolin (10 &#x3bc;M) up to 30 min followed by Western blot using the antibodies for phosphorylated form (&#x201c;P&#x201d;-form) of NFAT<sub>1</sub> and NFAT<sub>2</sub>, respectively. Given that no specific signals could be detected using the antibodies for total protein of NFAT<sub>1</sub> and NFAT<sub>2</sub> provided by the company, Western blot for tubulin was used as the internal control along with the parallel blotting for &#x3b2; actin as loading control.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g010.tif"/>
</fig>
</sec>
<sec id="s3_6">
<label>3.6</label>
<title>Coupling of Ca<sup>2+</sup>/CaM-dependent pathway with cAMP/PKA signalling in PRL regulation</title>
<p>In our previous studies with carp pituitary cells, the GH-releasing effect mediated by cAMP-dependent pathway (e.g., induced by forskolin) was found to be Ca<sup>2+</sup>-dependent and required the entry of extracellular Ca<sup>2+</sup> ([Ca<sup>2+</sup>]e) via VSCC (<xref ref-type="bibr" rid="B57">57</xref>). Since GH and PRL are evolved from the same ancestral gene, it would be of interest to know if a similar crosstalk between cAMP- and Ca<sup>2+</sup>-dependent cascades also plays a role in PRL regulation. As shown in <xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11A</bold>
</xref>, treatment with the AC activator forskolin (10 &#x3bc;M) could induce a rapid rise in [Ca<sup>2+</sup>]i in RPD cells and this Ca<sup>2+</sup> response was totally abolished in the presence of the PKA inhibitor H89 (20 &#x3bc;M) or L-type VSCC blocker nicardipine (5 &#x3bc;M). In pituitary cells prepared from carp pituitaries, forskolin treatment (10 &#x3bc;M) consistently increased PRL secretion and PRL mRNA levels and these PRL responses could be reduced/obliterated by the L-type VSCC blocker nicardipine (5 &#x3bc;M) or CaM antagonist calmidazolium (1 &#x3bc;M) (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11B</bold>
</xref>). Similar treatment with the CaMK-II inhibitor KN62 (5 &#x3bc;M) could also block the PRL-releasing effect of forskolin (10 &#x3bc;M) but not the corresponding response on PRL transcript. However, parallel treatment with the CaN inactivator cyclosporin A (100 nM) was found to reduce the PRL gene expression caused by forskolin with no effect on its stimulation for PRL release (<xref ref-type="fig" rid="f11">
<bold>Figure&#xa0;11C</bold>
</xref>). Given that CaM expression at pituitary level was previously shown to be a modulatory target involved in GH (<xref ref-type="bibr" rid="B58">58</xref>) and PRL regulation in grass carp (<xref ref-type="bibr" rid="B55">55</xref>), the effect of GnRH on CaM expression was also examined in carp RPD cells. In this case, sGnRH-A treatment (1 &#x3bc;M) could up-regulate CaM mRNA levels in our cell model and this CaM response could be blocked by the G<sub>s</sub> inhibitor melittin (100 nM) but not G<sub>q/11</sub> inhibitor YM254890 (1 &#x3bc;M) (<xref ref-type="fig" rid="f12">
<bold>Figure&#xa0;12A</bold>
</xref>). Similar to the PRL responses in preceding study, the stimulatory effect of sGnRH-A (1 &#x3bc;M) on CaM gene expression was totally negated by co-treatment with the AC inhibitor MDL 12330A (20 &#x3bc;M), PKA repressor H89 (20 &#x3bc;M), CREB inactivator KG-501 (10 &#x3bc;M) or CREB:CBP interaction blocker SGC-CBP30 (10 &#x3bc;M) (<xref ref-type="fig" rid="f12">
<bold>Figures&#xa0;12B, C</bold>
</xref>). As shown by Western blot in RPD cells, increasing levels of sGnRH-A (10&#x2013;1000 nM) was also effective in elevating protein expression of CAM in a dose-dependent manner (<xref ref-type="fig" rid="f12">
<bold>Figure&#xa0;12D</bold>
</xref>) and this stimulatory effect could be mimicked by parallel exposure to the AC stimulator forskolin (10 &#x3bc;M), cell-permeant cAMP analog 8Br.cAMP (1 mM), and PKA-specific cAMP analog 6-Bnz-cAMP (1 mM) but not the PKC activator TPA (1 &#x3bc;M) (<xref ref-type="fig" rid="f12">
<bold>Figure&#xa0;12E</bold>
</xref>).</p>
<fig id="f11" position="float">
<label>Figure&#xa0;11</label>
<caption>
<p>Functional coupling of cAMP/PKA-dependent pathway with Ca<sup>2+</sup>/CaM-dependent signalling on PRL release and PRL mRNA expression in carp pituitary cells. <bold>(A)</bold> Ca<sup>2+</sup> entry through L-type VSCC induced by forskolin via PKA activation in carp RPD cells. RPD cells preloaded with the Ca<sup>2+</sup> sensitive dye Fura-2 were challenged with the AC activator forskolin (10 &#x3bc;M) with/without the co-treatment of the L-type VSCC blocker nicardipine (5 &#x3bc;M) or PKA inactivator H89 (20 &#x3bc;M). During the process, the kinetics of Ca<sup>2+</sup> response was monitored based on the ratio of fluorescence output with excitation wavelength alternating between 340 nm and 380 nm (as &#x201c;F340/F380&#x201d;). <bold>(B)</bold> L-type VSCC blockade and CaM antagonism, and <bold>(C)</bold> CaMK-II and CaN inactivation on PRL release and PRL mRNA expression induced by forskolin in carp pituitary cells. In these experiments, pituitary cells were treated for 48 hr with forskolin (10 &#x3bc;M) in the presence or absence of the L-type VSCC inactivator nicardipine (5 &#x3bc;M), CaM antagonist calmidazolium (1 &#x3bc;M), CaMK-II inhibitor KN62 (5 &#x3bc;M), or CaN repressor cyclosporin A (100 nM). Groups denoted by different letters represent a significant difference at p &lt; 0.05.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g011.tif"/>
</fig>
<fig id="f12" position="float">
<label>Figure&#xa0;12</label>
<caption>
<p>CaM expression induced by GnRH via cAMP/PKA-dependent pathway in carp RPD cells. <bold>(A)</bold> Signal coupling via G<sub>s</sub> and G<sub>q/11</sub>, <bold>(B)</bold> Blockade of AC and PKA, and <bold>(C)</bold> Inhibiting CREB or interfering CREB: CBP interaction on CaM mRNA expression induced by GnRH. RPD cells were treated for 48 hr with sGnRH-A (1 &#x3bc;M) with/without the co-treatment of the G<sub>s</sub> inactivator melittin (100 nM), G<sub>q/11</sub> inhibitor YM254890 (1 &#x3bc;M), AC repressor MDA 12330A (20 &#x3bc;M), PKA inhibitor H89 (20 &#x3bc;M), CREB inactivator KG-501 (10 &#x3bc;M), or CREB: CBP interaction blocker SGC-CBP30 (10 &#x3bc;M). Groups denoted by different letters represent a significant difference at p &lt; 0.05. <bold>(D)</bold> Increasing doses of GnRH stimulation, and <bold>(E)</bold> PKA and PKC activation on CaM protein expression in carp RPD cells. RPD cells were challenged for 48 hrs with increasing concentrations of sGnRH-A (10&#x2013;1000 nM) or a fixed dose of sGnRH-A (1 &#x3bc;M), cell-permeable cAMP analog 8Br.cAMP (1 mM), PKC activator TPA (1 &#x3bc;M), AC activator forskolin (10 &#x3bc;M), and PKA-specific cAMP analog 6-Bnz-cAMP (1 mM), respectively. After treatment, cell lysate was prepared and subjected to Western blot using the antibody for CaM. Parallel Western blot for &#x3b2; actin was also conducted to serve as the loading control.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g012.tif"/>
</fig>
</sec>
</sec>
<sec id="s4" sec-type="discussion">
<label>4</label>
<title>Discussion</title>
<p>In vertebrate species, the pivotal role of GnRH in reproduction, especially via LH and FSH regulation, is well-conserved from fish to mammals (for review, see (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>)). In mammals, GnRH-induced PRL release has been reported <italic>in vivo</italic> in ovariectomized monkey (<xref ref-type="bibr" rid="B42">42</xref>) and in human female with HMG treatment during assisted reproduction (<xref ref-type="bibr" rid="B41">41</xref>). The <italic>in vitro</italic> studies for PRL regulation via pituitary action of GnRH, however, are not consistent and vary with sex, reproductive stages and neonatal development. For examples, PRL secretion induced by GnRH was demonstrated in pituitary fragments/pituitary cells prepared from human (<xref ref-type="bibr" rid="B64">64</xref>), sheep (<xref ref-type="bibr" rid="B43">43</xref>) and neonatal rat (<xref ref-type="bibr" rid="B65">65</xref>) but not in other species (e.g., in porcine pituitary cells) (<xref ref-type="bibr" rid="B44">44</xref>, <xref ref-type="bibr" rid="B45">45</xref>). Of note, the PRL-releasing effect of GnRH was observed in pituitary cells prepared from female sheep during the breeding season but not in other time of the year (<xref ref-type="bibr" rid="B43">43</xref>). In male rats, PRL secretion was not affected by GnRH treatment (<xref ref-type="bibr" rid="B66">66</xref>) but GnRH-induced PRL release could be noted in pituitary cells prepared from female rats during the neonatal period of day 3&#x2013;9 after birth (<xref ref-type="bibr" rid="B65">65</xref>). For the post-receptor signalling mediating PRL regulation by GnRH, the information available was based on GGH3 cell lines with functional expression of rat GnRHR. In this case, PRL release could be triggered by GnRH with a parallel rise in IP<sub>3</sub> levels (<xref ref-type="bibr" rid="B46">46</xref>) and mediated by cAMP signals and protein synthesis coupled with G<sub>s</sub> activation (<xref ref-type="bibr" rid="B47">47</xref>). Despite the fact that PRL also plays a key role in reproduction (see introduction), no consensus has been reached for the physiological role of PRL regulation by GnRH. For comparative studies on the same topic, only five reports have been published and they are all based on fish models, with two in tilapia, one in sockeye salmon, and the other two in masu salmon. For the studies in tilapia, <italic>in vitro</italic> culture of RPD/RPD cells prepared from male tilapia were used and the three native forms of GnRHs (with potency of GnRH2 &gt; GnRH1 &gt; GnRH3) were shown to induce PRL secretion (<xref ref-type="bibr" rid="B52">52</xref>) via PLC/IP<sub>3</sub>- and Ca<sup>2+</sup>-dependent mechanisms (<xref ref-type="bibr" rid="B51">51</xref>). For the reports in salmon, the focus was on pituitary gene expression and PRL mRNA levels in the pituitary of masu salmon (<xref ref-type="bibr" rid="B67">67</xref>) but not sockeye salmon (<xref ref-type="bibr" rid="B54">54</xref>) could be elevated by long-term implantation with GnRH. Similar to the study in sheep model, GnRH could up-regulate PRL mRNA expression in pituitary cells prepared from female masu salmon during pre-spawning phase but not in other reproductive stages (<xref ref-type="bibr" rid="B53">53</xref>). To date, the studies on signal transduction for the PRL-releasing effect of GnRH are rather limited and no information is available for the post-receptor signalling mediating the pituitary action of GnRH on PRL gene expression.</p>
<p>In fish models, nerve fibres with GnRH immunoreactivity are located in close proximity to lactotrophs (e.g., in perch) (<xref ref-type="bibr" rid="B68">68</xref>) and GnRHR expression can be detected in lactotrophs in the anterior pituitary (e.g., in tilapia) (<xref ref-type="bibr" rid="B38">38</xref>). These findings provide the initial support for lactotrophs as the target cells for GnRH within the fish pituitary. In grass carp, two forms of GnRH, GnRH2 and GnRH3, and four types of GnRHR of the GnRHR-II family, namely GnRHR<sub>1&#x2013;4</sub>, have been cloned recently (<xref ref-type="bibr" rid="B35">35</xref>). In our study, GnRHR<sub>1&#x2013;4</sub> expression could be located in the hypothalamo-pituitary axis of grass carp, which is consistent with the role of GnRH as a hypophysiotropic factor for gonadotropin regulation in carp species. Of note, the transcript expression of GnRHR<sub>1&#x2013;4</sub> could be detected by RT-PCR in intact pituitary but the corresponding signal of GnRHR<sub>3</sub> was missing in parallel study with freshly dispersed pituitary cells. Since the washing steps with cell pelleting by low-speed centrifugation used in our pituitary cell preparation (<xref ref-type="bibr" rid="B56">56</xref>) are known to remove cell debris and nerve fibres/terminals, we do not exclude the possibility that GnRHR<sub>3</sub> is expressed in nerve fibres/terminals but not in endocrine cells within the carp pituitary. Using RT-PCR coupled to LCM capture of pituitary cells with PRL immunoreactivity, only the transcript signal for GnRHR<sub>4</sub> but not the other GnRHRs was found in carp lactotrophs. In carp pituitary cells prepared from whole pituitaries, PRL release, PRL mRNA level and PRL protein production could be elevated by sGnRH-A, a GnRH agonist commonly used in induced spawning in fish farms (<xref ref-type="bibr" rid="B62">62</xref>), and these stimulatory effects were also mimicked by parallel treatment with the native forms of GnRH, namely GnRH2 and GnRH3. These results suggest that GnRH can act directly at the pituitary level to stimulate PRL secretion, gene expression and protein translation, probably via GnRHR<sub>4</sub> activation in carp lactotrophs. Using functional expression of GnRHR in HEK293 cells, the four GnRHRs in grass carp were shown to have differential selectivity for the two native forms of GnRH, with GnRHR<sub>1</sub> exhibiting a strong preference for GnRH3, GnRHR<sub>2</sub> and GnRHR<sub>3</sub> with higher selectivity for GnRH2, and GnRHR<sub>4</sub> with similar preference for GnRH2 and GnRH3 (<xref ref-type="bibr" rid="B35">35</xref>). Our dose-dependence studies with GnRH2 and GnRH3 in carp pituitary cells revealed that the potency and efficacy for PRL release caused by the two forms of GnRH were quite comparable and the promiscuity of the PRL-releasing effect for the two GnRHs is consistent with the ligand selectivity of GnRHR<sub>4</sub>. Interestingly, the corresponding effects on PRL mRNA expression were found to be more selective for GnRH3 than GnRH2 in terms of the maximal responses and ED<sub>50</sub> values. These results are intriguing and demonstrate for the first time that the ligand selectivity of GnRHR may vary with the biological readout in the same cell model. The higher sensitivity of GnRH3 for PRL gene expression also raises the possibility that GnRH3 may act as the major signal for PRL regulation by GnRH in carp lactotrophs, which corroborates with the role of GnRH3 as the &#x201c;hypophysiotropic GnRH&#x201d; for seasonal breeding in cyprinid species (<xref ref-type="bibr" rid="B5">5</xref>). Based on previous studies with domain swapping/deletion of C-terminal tail in GnRHRs from GnRHR-I and -II families (see introduction), it is commonly accepted that GnRHR-I without C-terminal tail is resistant to GnRH desensitization and the opposite is true for GnRHR-II with a C-terminal tail. In grass carp, GnRHR<sub>4</sub> expressed in lactotrophs is a member of GnRHR-II with a C-terminal tail typical of GPCR (<xref ref-type="bibr" rid="B35">35</xref>) and yet the PRL responses in terms of hormone secretion, transcript expression and protein production could still be noted after a 48-hr treatment with sGnRH-A, GnRH2 and GnRH3 at micromolar dose. These findings are at variance with the results expected for GnRHR-II (i.e., with refractoriness/even loss of response after prolonged induction) and suggest that GnRHR<sub>4</sub> expressed in carp lactotrophs is also resistant to GnRH desensitization similar to GnRHR-I.</p>
<p>In mammals, GnRHR can trigger post-receptor signalling via a single type/multiple types of G proteins in different cells/tissues in a context-dependent manner, e.g., with G<sub>q/11</sub> coupling in pituitary gonadotrophs, G<sub>q/11</sub> and G<sub>s</sub> coupling in hypothalamic neurons and G<sub>i</sub> coupling in cancer cells (e.g., prostate cancer) (<xref ref-type="bibr" rid="B69">69</xref>). Based on sequence mutations/domain swapping in rodent GnRHR expressed in COS-7/GGH3 cell lines, the 2<sup>nd</sup> and 3<sup>rd</sup> intracellular loops have been confirmed to be the structural domains in GnRHR for functional coupling with G<sub>s</sub> and G<sub>q/11</sub> (<xref ref-type="bibr" rid="B70">70</xref>, <xref ref-type="bibr" rid="B71">71</xref>) and activation of these G proteins upon ligand binding in GnRHR can lead to signal transduction via the PLC/IP<sub>3</sub>/PKC, AC/cAMP/PKA, MAPK and Ca<sup>2+</sup>-dependent cascades (<xref ref-type="bibr" rid="B24">24</xref>, <xref ref-type="bibr" rid="B25">25</xref>). For LH release induced by GnRH, the PLC/IP<sub>3</sub>/PKC pathway with IP<sub>3</sub>-mediated [Ca<sup>2+</sup>]i release and PKC coupling with MAPK forms a major core of the post-receptor signalling for GnRH at the pituitary level and the AC/cAMP/PKA pathway is not involved (<xref ref-type="bibr" rid="B27">27</xref>). In fish models, despite the similarity for the involvement of PLC/IP<sub>3</sub>/PKC pathway and the associated Ca<sup>2+</sup> responses (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B63">63</xref>), discrepancy on the role of cAMP in GnRH signalling has been reported, e.g., the cAMP-dependent signalling is absent in the LH-releasing effect of GnRH in goldfish (<xref ref-type="bibr" rid="B26">26</xref>) and catfish pituitary cells (<xref ref-type="bibr" rid="B72">72</xref>) but cAMP/PKA involvement in gonadotropin regulation by GnRH has been documented in tilapia (<xref ref-type="bibr" rid="B63">63</xref>) and more recently in grass carp (<xref ref-type="bibr" rid="B35">35</xref>). Although PRL release induced by GnRH mediated by G<sub>s</sub> and cAMP has been reported in GGH3 cells with stable transfection of rat GnRHR (<xref ref-type="bibr" rid="B47">47</xref>), whether the phenomenon can occur in primary culture of pituitary cells has yet to be examined. In our study with carp pituitary cells, AC activation by forskolin or increasing functional level of cAMP by 8Br.cAMP was shown to elevate PRL release and PRL mRNA levels and these stimulatory effects could be mimicked by the cAMP analog specific for PKA (6-Bnz-cAMP) but not Epac (pCPT-O-Me-cAMP), implying that activation of AC/cAMP/PKA pathway can trigger PRL secretion and gene expression in carp lactotrophs. This idea agrees with our findings that the PRL responses caused by forskolin could be blocked by AC inhibition with MDL 12330A or PKA inactivation by H89. For the role of cAMP-dependent pathway in PRL regulation by GnRH, GnRH treatment in carp RPD cells could trigger parallel rises in cAMP production and CREB phosphorylation followed by nuclear translocation of CREB, and these signalling events were mimicked by AC activation with forskolin. In parallel experiments with carp pituitary cells, the stimulatory effects of GnRH on PRL secretion and transcript expression were found to be sensitive to G<sub>s</sub> blockade by melittin, AC inhibition by MDL 12330A, and PKA inactivation by H89. Consistent with the idea of PKA phosphorylation of CREB followed by its nuclear translocation and recruitment of the co-activator CBP to initiate target gene transcription (<xref ref-type="bibr" rid="B73">73</xref>), PRL gene expression induced by GnRH could be negated by inactivating CREB with KG-501 or interfering CREB: CBP interaction by SGC-CBP30. Our findings, as a whole, suggest that PRL release and gene expression caused by GnRH in carp lactotrophs are mediated by G<sub>s</sub> activation coupled to AC/cAMP/PKA pathway. As a well-conserved CRE site can be located upstream of the TATA box within the 5&#x2019;promoter of grass carp PRL gene, the PRL mRNA response caused by GnRH probably is the result of PRL gene transcription mediated by CREB/CBP complex acting at the promoter level. Given that (i) chromatin remodelling is involved in GnRH-induced gonadotropin gene expression (<xref ref-type="bibr" rid="B74">74</xref>), (ii) CBP can induce histone acetylation via its intrinsic HAT activity/by recruitment of PCAF (<xref ref-type="bibr" rid="B75">75</xref>), and (iii) PRL mRNA expression induced by GnRH in carp pituitary cells was also sensitive to the blockade of HAT activity with C646, we do not exclude the possibility that modulation of chromatin packaging via CREB/CBP complex coupled with the cAMP-dependent pathway may play a role in PRL gene transcription induced by GnRH in carp species.</p>
<p>In RPD culture prepared from tilapia pituitaries, PRL secretion could be induced by GnRH with parallel rises in IP<sub>3</sub> levels and [Ca<sup>2+</sup>]i signals and this PRL-releasing effect was ablated by PLC inactivation, VSCC blockade and inhibition of [Ca<sup>2+</sup>]i mobilization (<xref ref-type="bibr" rid="B51">51</xref>). Although the functional role of PKC on PRL secretion was not examined, the results suggest that the PLC/IP<sub>3</sub> pathway and associated Ca<sup>2+</sup> responses are involved in PRL regulation by GnRH in fish model. In our study, PRL release and PRL mRNA levels could be up-regulated in carp pituitary cells by the DAG analog DiC8 or PKC activator TPA and these effects could be blocked by inactivating PKC with calphostin C, suggesting that PKC activation by DAG can induce PRL secretion and gene expression in carp lactotrophs. In carp pituitary cells, PRL release induced by GnRH was sensitive to G<sub>q/11</sub> inhibition with YM254890, PLC blockade by U73122, and PKC repression using calphostin C. Although G<sub>q/11</sub> inhibition could suppress PRL transcript expression caused by GnRH, similar blockade of PLC and PKC was found to have no effect in this regard. Furthermore, IP<sub>3</sub> antagonism with xestospongin C or blocking IP<sub>3</sub> channel for [Ca<sup>2+</sup>]i mobilization with 2-APB did not alter GnRH-induced PRL release and gene expression. These results suggest that G<sub>q/11</sub> activation induced by GnRH can trigger PRL release in carp lactotrophs via PLC/PKC pathway and the IP<sub>3</sub> component working downstream of PLC is not involved. Apparently, PRL gene expression caused by GnRH is not mediated by the PLC/IP<sub>3</sub>/PKC pathway, which is consistent with our findings that the PKC-sensitive transcription factors, namely c-Fos and c-Jun, did not show noticeable changes in carp RPD cells with GnRH treatment. In our study, PKC activation by TPA or DiC8 could elevate PRL mRNA levels but similar response on PRL gene expression by GnRH did not involve PKC signalling and yet PKC involvement has been clearly implicated for the PRL-releasing effect of GnRH. In living cells, multiple forms of PKC are expressed and TPA and DAG are known to activate the conventional (PKC<sub>&#x3b1;, &#x3b2; &amp; &#x3b3;</sub>) and novel PKCs (PKC<sub>&#x3b4;, &#x3b5;, &#x3b7; &amp; &#x3b8;</sub>) but not atypical PKCs (PKC<sub>&#x3b6; &amp; &#x3b9;)</sub> (<xref ref-type="bibr" rid="B76">76</xref>). It is tempting to speculate that a subtype of atypical PKCs may be involved in PRL release but not gene expression induced by GnRH. Of note, G<sub>q/11</sub> inhibition could block PRL transcript expression caused by GnRH and yet the PLC/IP<sub>3</sub>/PKC pathway coupled to G<sub>q/11</sub> was not involved, functional mediation by other signalling events working downstream of G<sub>q/11</sub> (e.g., MAPK) for PRL gene transcription cannot be excluded.</p>
<p>Although [Ca<sup>2+</sup>]i mobilization via IP<sub>3</sub> is well-documented for the LH-releasing effect of GnRH, voltage-gated [Ca<sup>2+</sup>]e influx caused by functional interplay of a combination of ion channels also contributes to the LH response via the action potentials and Ca<sup>2+</sup> oscillations induced by GnRH at the gonadotroph level (<xref ref-type="bibr" rid="B77">77</xref>). The involvement of [Ca<sup>2+</sup>]i mobilization and voltage-gated [Ca<sup>2+</sup>]e entry is well-conserved in GnRH actions in fish species, e.g., for GnRH-induced LH and GH release in goldfish pituitary cells (<xref ref-type="bibr" rid="B26">26</xref>, <xref ref-type="bibr" rid="B27">27</xref>). In our study, VSCC activation by Bay K8644 was effective in triggering a rapid rise in cytosolic Ca<sup>2+</sup> in carp RPD cells and this effect was blocked by inhibiting L-type VSCC with nicardipine. Bay K8644 also increased PRL release and PRL mRNA level in carp pituitary cells and these stimulatory actions could be nullified by L-type VSCC inactivation using nicardipine or CaM antagonism by calmidazolium. For the signalling events working downstream of CaM, blocking CaMK-II activity by KN62 was found to ablate the PRL-releasing effect of Bay K8644 but not the corresponding response on PRL mRNA, whereas the opposite was true for parallel inhibition of CaN using cytosporin A. These results imply that [Ca<sup>2+</sup>]e entry via L-type VSCC can trigger PRL responses via Ca<sup>2+</sup>/CaM-dependent signalling, with PRL release caused by CaMK-II activation and PRL gene expression mediated by CaN-dependent mechanisms. In carp RPD cells, GnRH was effective in inducing Ca<sup>2+</sup> signals, which could be negated by nicardipine inhibition of L-type VSCC. Parallel kinetic chase of the spatiotemporal distribution of the Ca<sup>2+</sup> signals in immuno-identified lactotrophs also revealed that the Ca<sup>2+</sup> rise caused by GnRH was initiated close to the plasma membrane and spread into the central region of responsive cells, which is consistent with [Ca<sup>2+</sup>]e entry via VSCC at the membrane level. During the process, the highest level of Ca<sup>2+</sup> signals was located in the subplasmalemmal space under the plasma membrane, which is well-documented to be the region with the readily releasable pool of secretory vesicles with proper priming/docking for Ca<sup>2+</sup>-sensitive exocytosis in endocrine cells (<xref ref-type="bibr" rid="B78">78</xref>). In carp pituitary cells, PRL secretion and gene expression caused by GnRH were also sensitive to VSCC blockade with nicardipine and CaM antagonism with calmidazolium. For the downstream events coupled to Ca<sup>2+</sup>/CaM signalling, the PRL-releasing effect of GnRH but not the corresponding action on PRL transcript could be obliterated by inactivating CaMK-II with KN62. However, the elevation in PRL mRNA levels but not PRL release caused by GnRH was reduced/nullified by blocking CaN with cyclosporin A, interfering CaN:NFAT interaction by INCA-6, or inhibiting nuclear translocation of NFAT using 11R-VIVIT. These results are also consistent with our finding that GnRH treatment was effective in reducing NFAT<sub>2</sub> phosphorylation in carp RPD cells. Since (i) CaMK-II activation by Ca<sup>2+</sup>/CaM complex can phosphorylate exocytosis regulators (e.g., syntaxin and synapsin) for priming/docking of secretory vesicles at membrane level prior to their exocytosis (<xref ref-type="bibr" rid="B79">79</xref>), (ii) CaN is a serine/threonine phosphatase and its enzyme activity can be up-regulated by Ca<sup>2+</sup>/CaM signalling to trigger gene transcription via NFAT dephosphorylation (<xref ref-type="bibr" rid="B80">80</xref>), and (iii) three NFAT binding sites with the proximal one overlapping with the CRE site upstream of the TATA box can be located in the 5&#x2019; promoter of grass carp PRL gene, our findings may imply that Ca<sup>2+</sup>/CaM signalling caused by [Ca<sup>2+</sup>]e entry via L-type VSCC is involved in PRL regulation by GnRH. Apparently, the PRL-releasing effect is mediated by Ca<sup>2+</sup>/CaM activation of CaMK-II and the corresponding response for PRL transcript is caused by PRL gene transcription via parallel activation of CaN/NFAT<sub>2</sub>. In grass carp, differential involvement of CaMK-II and CaN/NFAT in negative feedback of GH by IGF-I has also been reported (<xref ref-type="bibr" rid="B58">58</xref>). In this case, IGF-I could inhibit GH gene transcription in carp pituitary cells by elevating CaM expression with parallel rises in CaN/NFAT but not CaMK-II signalling. In carp RPD cells, the Ca<sup>2+</sup> responses for GnRH could be totally negated by nicardipine and this observation suggest that the Ca<sup>2+</sup> signals in lactotrophs caused by GnRHR activation are mainly of extracellular origin. Together with our findings that IP<sub>3</sub> antagonism/IP<sub>3</sub> channel blockade did not alter the PRL responses by GnRH, it would be logical to assume that IP<sub>3</sub>-induced [Ca<sup>2+</sup>]i mobilization is not a major component in the signal transduction for PRL regulation by GnRH. This idea, however, is at variance with the reports on LH release induced by GnRH, in which the PLC/IP<sub>3</sub> pathway coupled to [Ca<sup>2+</sup>]i mobilization forms a major core of the post-receptor signalling in gonadotrophs (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B27">27</xref>).</p>
<p>In grass carp, the proximal NFAT binding site was found to overlap with the CRE site identified in the 5&#x2019;promoter of PRL gene, which raises the possibility that a functional crosstalk between cAMP- and Ca<sup>2+</sup>-dependent pathways may be involved in PRL regulation in carp species. In fish models, functional coupling of cAMP/PKA pathway with Ca<sup>2+</sup>-dependent signalling has been reported for pituitary hormone secretion/gene expression. For examples, cAMP signalling coupled with Ca<sup>2+</sup> entry via VSCC was shown to mediate GH secretion induced by dopamine via D1 receptor activation in goldfish pituitary cells (<xref ref-type="bibr" rid="B81">81</xref>, <xref ref-type="bibr" rid="B82">82</xref>). In carp pituitary cells, PACAP via PAC1 receptor activation can act as a potent stimulator for GH (<xref ref-type="bibr" rid="B57">57</xref>), PRL (<xref ref-type="bibr" rid="B55">55</xref>) and SL&#x3b1; gene expression (<xref ref-type="bibr" rid="B83">83</xref>), and these stimulatory effects also involve cAMP/PKA-mediated Ca<sup>2+</sup> entry via VSCC and Ca<sup>2+</sup>/CaM activation of CaMK-II. In our previous study in grass carp, CaM gene was cloned, and its promoter activity was shown to be under the control of cAMP signalling (<xref ref-type="bibr" rid="B84">84</xref>). Furthermore, CaM expression in carp pituitary cells could be up-regulated by PACAP in a cAMP/PKA-dependent manner (<xref ref-type="bibr" rid="B55">55</xref>) and contributes to PACAP-induced PRL promoter activition (<xref ref-type="bibr" rid="B85">85</xref>) and transcript expression (<xref ref-type="bibr" rid="B55">55</xref>). Apparently, the crosstalk of cAMP pathway with Ca<sup>2+</sup>-dependent signalling can occur at two levels in the carp pituitary, with (i) VSCC activation to allow [Ca<sup>2+</sup>]e entry to jack up cytosolic Ca<sup>2+</sup> and (ii) increasing CaM expression to enhance the sensitivity to Ca<sup>2+</sup> signals. In our study with carp RPD cells, a rise in Ca<sup>2+</sup> signal was noted with AC activation by forskolin and this Ca<sup>2+</sup> response could be blocked by inhibiting L-type VSCC with nicardipine or PKA inactivation using H89, suggesting that L-type VSCC can be activated by cAMP signal in lactotrophs via PKA activation. This idea also corroborates with the reports that the ion channel activity of VSCC can be altered by protein phosphorylation (<xref ref-type="bibr" rid="B86">86</xref>), e.g., enhancement of inward Ca<sup>2+</sup> current/channel opening probability is well-documented for PKA phosphorylation of Ca<sub>V</sub>1.4 (<xref ref-type="bibr" rid="B87">87</xref>) and Ca<sub>V</sub>1.2a,b subtypes of L-type VSCC (<xref ref-type="bibr" rid="B88">88</xref>). In carp pituitary cells, VSCC inhibition with nicardipine and CaM antagonism with calmidazolium were both effective in blocking PRL release and PRL gene expression caused by forskolin. Furthermore, the PRL-releasing effect of forskolin but not the parallel stimulation on PRL mRNA could be ablated by CaMK-II inhibition with KN62 while the opposite was true with CaN inactivation by cyclosporin A. Similar to GnRH, forskolin also induced NFAT<sub>2</sub> dephosphorylation in carp RPD cells. In the same cell model, CaM expression could be up-regulated by GnRH and the effect was mimicked by AC activation with forskolin, increasing cAMP level by 8Br.cAMP, and PKA activation using 6-Bnz-cAMP. Consistent with CaM expression at protein level, GnRH treatment could also increase CaM mRNA level in RPD cells, and the effect was sensitive to G<sub>s</sub> inhibition using melittin, AC repression by MDL 12330A, PKA blockade with H89, CREB inactivation by KG-501, and blocking CREB:CBP interaction by SGC-CBP30. These findings, as a whole, imply that (i) the Ca<sup>2+</sup>/CaM-dependent signalling with involvement of CaMK-II in PRL secretion and CaN/NFAT in PRL gene expression are working downstream of the cAMP/PKA pathway coupled with G<sub>s</sub> signalling, and (ii) the crosstalk between cAMP- and Ca<sup>2+</sup>-dependent cascades induced by GnRH in carp lactotrophs probably is mediated by [Ca<sup>2+</sup>]e entry via PKA activation of L-type VSCC and CaM expression coupled with AC/cAMP/PKA signalling via CREB/CBP-dependent gene transcription.</p>
<p>In summary, using grass carp pituitary cells as a model, we have demonstrated for the first time that the cAMP/PKA-, PLC/PKC- and Ca<sup>2+</sup>/CaM-dependent signalling are differentially involved in PRL secretion and gene expression induced by GnRH at the pituitary level. Based on the results obtained, a working model has been proposed for the signal transduction mediating PRL regulation by GnRH in carp lactotrophs (<xref ref-type="fig" rid="f13">
<bold>Figure&#xa0;13</bold>
</xref>). In this model, GnRHR<sub>4</sub> activation in lactotrophs by GnRH2/3 or their agonist sGnRH-A can initiate post-receptor signalling via G<sub>s</sub> and G<sub>q/11</sub> coupling. The AC/cAMP/PKA pathway and [Ca<sup>2+</sup>]e entry via L-type VSCC with subsequent Ca<sup>2+</sup>/CaM-activation of CaMK-II and CaN are coupled to G<sub>s</sub> activation while the PLC/IP<sub>3</sub>/PKC pathway with downstream PKC-dependent signalling and [Ca<sup>2+</sup>]i mobilization by IP<sub>3</sub> are linked with G<sub>q/11</sub> activation. Interestingly, different components of these signalling events are differentially involved in PRL secretion and gene expression by GnRH, with (i) the AC/cAMP/PKA, Ca<sup>2+</sup>/CaM/CaMK-II and PLC/DAG/PKC signalling responsible for the PRL-releasing effect, and (ii) PKA-induced CREB phosphorylation for nuclear entry and CBP recruitment and Ca<sup>2+</sup>/CaM-mediated NFAT<sub>2</sub> dephosphorylation by CaN to trigger PRL gene transcription with subsequent rise in PRL mRNA and protein synthesis. In carp lactotrophs, the Ca<sup>2+</sup>-dependent signalling via CaMK-II (for PRL release) and CaN activation (for PRL gene expression) is working downstream of the AC/cAMP/PKA pathway probably through (i) VSCC activation by PKA to induce [Ca<sup>2+</sup>]e entry at membrane level and (ii) CaM up-regulation via transcriptional activation by CREB/CBP coupled to cAMP/PKA signalling. Although the other aspects of post-receptor signalling (e.g., MAPK) have not been touched in PRL regulation in our cell model, our study has provided novel information on the complexity of signal transduction involved in PRL release and gene expression by GnRH in a carp species. Given that our study focused on the pituitary actions of GnRH using primary culture of pituitary cells, further investigations using an <italic>in vivo</italic> approach (e.g., for GnRH interactions with other PRL regulators of central origin/from the periphery or GnRHR knockout in lactotrophs using CRISPR/Cas9) are clearly warranted to establish a more holistic picture for the physiological role of GnRH in PRL regulation. It is also worth mentioning that the pituitary cells used in our study were prepared from pre-pubertal fish, it will be of interest to know if the post-receptor signalling for PRL regulation by GnRH can be modified/&#x201c;fine-tuned&#x201d; with sexual maturation/with different stages of the seasonal reproductive cycle in adult fish as in the case of gonadotropin secretion/gene expression.</p>
<fig id="f13" position="float">
<label>Figure&#xa0;13</label>
<caption>
<p>Working model for signal transduction involved in GnRH-induced PRL secretion and gene expression in carp lactotrophs. In this model, native GnRHs (GnRH2/3) or its functional agonists (e.g., sGnRH-A) bind with GnRHR<sub>4</sub> expressed in carp lactotrophs and induce post-receptor signalling via G<sub>s</sub> and G<sub>q/11</sub> coupling. G<sub>s</sub> coupling with AC can increase cAMP production to trigger PKA activation with rapid phosphorylation and nuclear translocation of CREB. Through binding with PRL promoter, CREB recruits the co-activator CBP to initiate PRL gene transcription and the subsequent rise in PRL transcript expression presumably can contribute to PRL exocytosis by increasing PRL synthesis. PKA activation can also induce [Ca<sup>2+</sup>]e entry via activation of L-type VSCC. The subsequent rise in Ca<sup>2+</sup> signals in the cytoplasm through binding with the Ca<sup>2+</sup> sensor CaM can induce PRL secretion via CaMK-II activation and elevate PRL transcript expression via CaN-induced dephosphorylation of NFAT<sub>2</sub>, which is assumed to work with CREB/CBP at the promoter level to trigger PRL gene transcription. CREB/CBP coupled to cAMP/PKA pathway can also induce CaM gene expression with subsequent rise in CaM signal to enhance Ca<sup>2+</sup>/CaM-dependent activation of CaMK-II and CaN/NFAT signalling. Parallel to the post-receptor signalling via G<sub>s</sub>, GnRHR<sub>4</sub> activation can also trigger PRL exocytosis via G<sub>q/11</sub> coupling to the PLC/DAG/PKC pathway. Apparently, [Ca<sup>2+</sup>]i mobilization by IP<sub>3</sub> working downstream of PLC is not involved in PRL secretion and gene expression induced by GnRH.</p>
</caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fendo-15-1399274-g013.tif"/>
</fig>
</sec>
<sec id="s5" sec-type="data-availability">
<title>Data availability statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="supplementary-material" rid="SM1">
<bold>Supplementary Material</bold>
</xref>. Further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6" sec-type="ethics-statement">
<title>Ethics statement</title>
<p>The animal study was approved by The Committee on the Use of Live Animal for Teaching and Research, the University of Hong Kong, Hong Kong. The study was conducted in accordance with the local legislation and institutional requirements.</p>
</sec>
<sec id="s7" sec-type="author-contributions">
<title>Author contributions</title>
<p>WL: Conceptualization, Data curation, Investigation, Methodology, Writing &#x2013; review &amp; editing, Formal analysis. CY: Data curation, Formal analysis, Investigation, Methodology, Software, Writing &#x2013; review &amp; editing. MH: Data curation, Formal analysis, Investigation, Methodology, Validation, Writing &#x2013; review &amp; editing. WK: Data curation, Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing &#x2013; review &amp; editing. CC: Conceptualization, Funding acquisition, Project administration, Supervision, Writing &#x2013; original draft. YC: Project administration, Supervision, Visualization, Writing &#x2013; review &amp; editing. AW: Conceptualization, Data curation, Formal analysis, Funding acquisition, Methodology, Project administration, Resources, Supervision, Writing &#x2013; original draft, Writing &#x2013; review &amp; editing.</p>
</sec>
</body>
<back>
<sec id="s8" sec-type="funding-information">
<title>Funding</title>
<p>The author(s) declare financial support was received for the research, authorship, and/or publication of this article. The project was supported by GRF Grants 17105819, 17103320, 17111221 and 17116022, Research Grant Council (Hong Kong).</p>
</sec>
<ack>
<title>Acknowledgments</title>
<p>Support from the School of Biological Sciences, University of Hong Kong, in the form of a postgraduate studentship (to CY) is acknowledged.</p>
</ack>
<sec id="s9">
<title>In memoriam</title>
<p>This paper is dedicated to Prof. Christopher H. K. Cheng (Chinese University of Hong Kong, HK), a collaborator and long-term friend who passed away before the project was completed. Chris&#x2019;s passion for comparative endocrinology will always be missed and the students he trained throughout the years (many of them are now prominent scientists in Hong Kong and mainland China) will continue to make notable contributions to our research community for years to come.</p>
</sec>
<sec id="s10" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
<p>The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</p>
</sec>
<sec id="s11" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s12" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fendo.2024.1399274/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fendo.2024.1399274/full#supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet_1.pdf" id="SM1" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet_2.pdf" id="SM2" mimetype="application/pdf"/>
<supplementary-material xlink:href="DataSheet_3.pdf" id="SM3" mimetype="application/pdf"/>
</sec>
<fn-group>
<title>Abbreviations</title>
<fn fn-type="abbr">
<p>PRL, Prolactin; LH, Luteinizing Hormone; FSH, Follicle Stimulating Hormone; GH, Growth Hormone, SL, Somatolactin; HMG, Human Menopausal Gonadotropin; GnRH, Gonadotropin-releasing Hormone; GnRHR, GnRH Receptor; sGnRH-A, Superactive [D-Arg<sup>6</sup>, Pro<sup>9</sup> NHEt]-sGnRH Analog; cAMP, Cyclic Adenosine Monophosphate; Epac, Exchange Protein Activated by cAMP; AC, Adenylate Cyclase; PKA, Protein Kinase A; PLC, Phospholipase C; DAG, Diacylglycerol; IP<sub>3</sub>, Inositol 1,4,5-Triphosphate; PKC, Protein Kinase C; [Ca<sup>2+</sup>]i/e, Intracellular and Extracellular Ca<sup>2+</sup>; CaM, Calmodulin; CaMK-II, Ca<sup>2+</sup>/CaM-dependent Protein Kinase-II; CaN, Calcineurin; NFAT, Nuclear Factor of Activated T Cells; CREB, CRE Binding Protein; CBP, CREB-binding Protein; HAT, Histone Acetyltransferase; AP-1, Activator Protein-1; AKH, Adipokinetic Hormone; CRZ, Corazonin; PACAP, Pituitary Adenylate Cyclase-activating Polypeptide; GPCR, G Protein-Coupled Receptor; TMD, Transmembrane Domain; KNDy Neurons, Kisspeptin-Neurokinin-Dynorphin Neurons; RPD, Rostral Pars Distalis; RIA, Radioimmunoassay; GSI, Gonadosomatic Index; ORF, Open Reading frame.</p>
</fn>
</fn-group>
<ref-list>
<title>References</title>
<ref id="B1">
<label>1</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sakai</surname> <given-names>T</given-names>
</name>
<name>
<surname>Shiraishi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kawada</surname> <given-names>T</given-names>
</name>
<name>
<surname>Matsubara</surname> <given-names>S</given-names>
</name>
<name>
<surname>Aoyama</surname> <given-names>M</given-names>
</name>
<name>
<surname>Satake</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Invertebrate gonadotropin-releasing hormone-related peptides and their receptors: an update</article-title>. <source>Front Endocrinol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>217</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2017.00217</pub-id>
</citation>
</ref>
<ref id="B2">
<label>2</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roch</surname> <given-names>GJ</given-names>
</name>
<name>
<surname>Busby</surname> <given-names>ER</given-names>
</name>
<name>
<surname>Sherwood</surname> <given-names>NM</given-names>
</name>
</person-group>. <article-title>GnRH receptors and peptides: skating backward</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2014</year>) <volume>209</volume>:<page-range>118&#x2013;34</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2014.07.025</pub-id>
</citation>
</ref>
<ref id="B3">
<label>3</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morgan</surname> <given-names>K</given-names>
</name>
<name>
<surname>Millar</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Evolution of GnRH ligand precursors and GnRH receptors in protochordate and vertebrate species</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2004</year>) <volume>139</volume>:<page-range>191&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2004.09.015</pub-id>
</citation>
</ref>
<ref id="B4">
<label>4</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okubo</surname> <given-names>K</given-names>
</name>
<name>
<surname>Nagahama</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Structural and functional evolution of gonadotropin-releasing hormone in vertebrates</article-title>. <source>Acta Physiol</source>. (<year>2008</year>) <volume>193</volume>:<fpage>3</fpage>&#x2013;<lpage>15</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1748-1716.2008.01832.x</pub-id>
</citation>
</ref>
<ref id="B5">
<label>5</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Munoz-Cueto</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Zmora</surname> <given-names>N</given-names>
</name>
<name>
<surname>Paullada-Salmeron</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Marvel</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mananos</surname> <given-names>E</given-names>
</name>
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>The gonadotropin-releasing hormones: lessons from fish</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2020</year>) <volume>291</volume>:<elocation-id>113422</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2020.113422</pub-id>
</citation>
</ref>
<ref id="B6">
<label>6</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Zmora</surname> <given-names>N</given-names>
</name>
<name>
<surname>Trudeau</surname> <given-names>VL</given-names>
</name>
<name>
<surname>Munoz-Cueto</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Golan</surname> <given-names>M</given-names>
</name>
</person-group>. <article-title>A half century of fish gonadotropin-releasing hormones: breaking paradigms</article-title>. <source>J Neuroendocrinol</source>. (<year>2022</year>) <volume>34</volume>:<fpage>e13069</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/jne.13069</pub-id>
</citation>
</ref>
<ref id="B7">
<label>7</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gonzalez-Martinez</surname> <given-names>D</given-names>
</name>
<name>
<surname>Madigou</surname> <given-names>T</given-names>
</name>
<name>
<surname>Zmora</surname> <given-names>N</given-names>
</name>
<name>
<surname>Anglade</surname> <given-names>I</given-names>
</name>
<name>
<surname>Zanuy</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Differential expression of three different prepro-GnRH messengers in the brain of the european sea bass (<italic>Dicentrarchus labrax</italic>)</article-title>. <source>J Comp Neurol</source>. (<year>2001</year>) <volume>429</volume>:<page-range>144&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/1096&#x2013;9861(20000101)429:1&lt;144::aid-cne11&gt;3.0.co;2-b</pub-id>
</citation>
</ref>
<ref id="B8">
<label>8</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somoza</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Miranda</surname> <given-names>LA</given-names>
</name>
<name>
<surname>Strobl-Mazzulla</surname> <given-names>P</given-names>
</name>
<name>
<surname>Guilgur</surname> <given-names>LG</given-names>
</name>
</person-group>. <article-title>Gonadotropin-releasing hormone: from fish to mammalian brains</article-title>. <source>Cell Mol Neurobiol</source>. (<year>2002</year>) <volume>22</volume>:<fpage>589</fpage>&#x2013;<lpage>609</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1023/a:1021888420271</pub-id>
</citation>
</ref>
<ref id="B9">
<label>9</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yamamoto</surname> <given-names>N</given-names>
</name>
</person-group>. <article-title>Three gonadotropin-releasing hormone neuronal groups with special reference to teleosts</article-title>. <source>Anat Sci Int</source>. (<year>2003</year>) <volume>78</volume>:<page-range>139&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.0022-7722.2003.00051.x</pub-id>
</citation>
</ref>
<ref id="B10">
<label>10</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Desaulniers</surname> <given-names>AT</given-names>
</name>
<name>
<surname>Cederberg</surname> <given-names>RA</given-names>
</name>
<name>
<surname>Lents</surname> <given-names>CA</given-names>
</name>
<name>
<surname>White</surname> <given-names>BR</given-names>
</name>
</person-group>. <article-title>Expression and role of gonadotropin-releasing hormone 2 and its receptor in mammals</article-title>. <source>Front Endocrinol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>269</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2017.00269</pub-id>
</citation>
</ref>
<ref id="B11">
<label>11</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oka</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Electrophysiological characteristics of gonadotrophin-releasing hormone 1&#x2013;3 neurones: insights from a study of fish brains</article-title>. <source>J Neuroendocrinol</source>. (<year>2010</year>) <volume>22</volume>:<page-range>659&#x2013;63</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1111/j.1365-2826.2010.02035.x</pub-id>
</citation>
</ref>
<ref id="B12">
<label>12</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Karigo</surname> <given-names>T</given-names>
</name>
<name>
<surname>Oka</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Neurobiological study of fish brains gives insights into the nature of gonadotropin-releasing hormone 1&#x2013;3 neurons</article-title>. <source>Front Endocrinol</source>. (<year>2013</year>) <volume>4</volume>:<elocation-id>177</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2013.00177</pub-id>
</citation>
</ref>
<ref id="B13">
<label>13</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Takahashi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Kanda</surname> <given-names>S</given-names>
</name>
<name>
<surname>Abe</surname> <given-names>T</given-names>
</name>
<name>
<surname>Oka</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Evolution of the hypothalamic-pituitary-gonadal axis regulation in vertebrates revealed by knockout medaka</article-title>. <source>Endocrinology</source>. (<year>2016</year>) <volume>157</volume>:<fpage>3994</fpage>&#x2013;<lpage>4002</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2016&#x2013;1356</pub-id>
</citation>
</ref>
<ref id="B14">
<label>14</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Greenwood</surname> <given-names>AK</given-names>
</name>
<name>
<surname>Fernald</surname> <given-names>RD</given-names>
</name>
</person-group>. <article-title>Social regulation of the electrical properties of gonadotropin-releasing hormone neurons in a cichlid fish (<italic>Astatotilapia burtoni</italic>)</article-title>. <source>Biol Reprod</source>. (<year>2004</year>) <volume>71</volume>:<page-range>909&#x2013;18</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1095/biolreprod.104.030072</pub-id>
</citation>
</ref>
<ref id="B15">
<label>15</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Constantin</surname> <given-names>S</given-names>
</name>
</person-group>. <article-title>Progress and challenges in the search for the mechanisms of pulsatile gonadotropin-releasing hormone secretion</article-title>. <source>Front Endocrinol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>180</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2017.00180</pub-id>
</citation>
</ref>
<ref id="B16">
<label>16</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kah</surname> <given-names>O</given-names>
</name>
<name>
<surname>Breton</surname> <given-names>B</given-names>
</name>
<name>
<surname>Dulka</surname> <given-names>JG</given-names>
</name>
<name>
<surname>Nunez-Rodriguez</surname> <given-names>J</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Corrigan</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>A reinvestigation of the GnRH systems in the goldfish brain using antibodies to salmon GnRH</article-title>. <source>Cell Tissue Res</source>. (<year>1986</year>) <volume>244</volume>:<page-range>327&#x2013;37</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/BF00219208</pub-id>
</citation>
</ref>
<ref id="B17">
<label>17</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ladisa</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Habibi</surname> <given-names>HR</given-names>
</name>
</person-group>. <article-title>Multifactorial control of reproductive and growth axis in male goldfish: influences of GnRH, gnIH and thyroid hormone</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2020</year>) <volume>500</volume>:<elocation-id>110629</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2019.110629</pub-id>
</citation>
</ref>
<ref id="B18">
<label>18</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Volkoff</surname> <given-names>H</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Actions of two forms of gonadotropin releasing hormone and a GnRH antagonist on spawning behavior of the goldfish, <italic>carassius auratus</italic>
</article-title>. <source>Gen Comp Endocrinol</source>. (<year>1999</year>) <volume>116</volume>:<page-range>347&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.1999.7377</pub-id>
</citation>
</ref>
<ref id="B19">
<label>19</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname> <given-names>MH</given-names>
</name>
<name>
<surname>Oka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Amano</surname> <given-names>M</given-names>
</name>
<name>
<surname>Kobayashi</surname> <given-names>M</given-names>
</name>
<name>
<surname>Okuzawa</surname> <given-names>K</given-names>
</name>
<name>
<surname>Hasegawa</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Immunocytochemical Localization of sGnRH and cGnRH-II in the Brain of Goldfish, <italic>Carassius Auratus</italic>
</article-title>. <source>J Comp Neurol</source>. (<year>1995</year>) <volume>356</volume>:<fpage>72</fpage>&#x2013;<lpage>82</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1002/cne.903560105</pub-id>
</citation>
</ref>
<ref id="B20">
<label>20</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname> <given-names>KL</given-names>
</name>
<name>
<surname>He</surname> <given-names>ML</given-names>
</name>
<name>
<surname>Chik</surname> <given-names>CC</given-names>
</name>
<name>
<surname>Lin</surname> <given-names>XW</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>RE</given-names>
</name>
</person-group>. <article-title>Messenger RNA expression of gonadotropin-releasing hormones (GnRH) and GnRH receptor in goldfish</article-title>. <source>Gen Comp Endocrinol</source>. (<year>1998</year>) <volume>112</volume>:<page-range>303&#x2013;11</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.1998.7137</pub-id>
</citation>
</ref>
<ref id="B21">
<label>21</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Klausen</surname> <given-names>C</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Habibi</surname> <given-names>HR</given-names>
</name>
</person-group>. <article-title>Time- and dose-related effects of gonadotropin-releasing hormone on growth hormone and gonadotropin subunit gene expression in the goldfish pituitary</article-title>. <source>Can J Physiol Pharmacol</source>. (<year>2002</year>) <volume>80</volume>:<page-range>915&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/y02&#x2013;118</pub-id>
</citation>
</ref>
<ref id="B22">
<label>22</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xia</surname> <given-names>W</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>O</given-names>
</name>
<name>
<surname>Zmora</surname> <given-names>N</given-names>
</name>
<name>
<surname>Xu</surname> <given-names>S</given-names>
</name>
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
</person-group>. <article-title>Comprehensive analysis of GnRH2 neuronal projections in zebrafish</article-title>. <source>Sci Rep</source>. (<year>2014</year>) <volume>4</volume>:<elocation-id>3676</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/srep03676</pub-id>
</citation>
</ref>
<ref id="B23">
<label>23</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steven</surname> <given-names>C</given-names>
</name>
<name>
<surname>Lehnen</surname> <given-names>N</given-names>
</name>
<name>
<surname>Kight</surname> <given-names>K</given-names>
</name>
<name>
<surname>Ijiri</surname> <given-names>S</given-names>
</name>
<name>
<surname>Klenke</surname> <given-names>U</given-names>
</name>
<name>
<surname>Harris</surname> <given-names>WA</given-names>
</name>
<etal/>
</person-group>. <article-title>Molecular characterization of the GnRH system in zebrafish (<italic>Danio rerio</italic>): cloning of chicken GnRH-II, adult brain expression patterns and pituitary content of salmon GnRH and chicken GnRH-II</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2003</year>) <volume>133</volume>:<fpage>27</fpage>&#x2013;<lpage>37</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0016&#x2013;6480(03)00144&#x2013;8</pub-id>
</citation>
</ref>
<ref id="B24">
<label>24</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cheng</surname> <given-names>KW</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>PC</given-names>
</name>
</person-group>. <article-title>The expression, regulation and signal transduction pathways of the mammalian gonadotropin-releasing hormone receptor</article-title>. <source>Can J Physiol Pharmacol</source>. (<year>2000</year>) <volume>78</volume>:<page-range>1029&#x2013;52</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/y00-096</pub-id>
</citation>
</ref>
<ref id="B25">
<label>25</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naor</surname> <given-names>Z</given-names>
</name>
</person-group>. <article-title>Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor</article-title>. <source>Front Neuroendocrinol</source>. (<year>2009</year>) <volume>30</volume>:<fpage>10</fpage>&#x2013;<lpage>29</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yfrne.2008.07.001</pub-id>
</citation>
</ref>
<ref id="B26">
<label>26</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Johnson</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Van Goor</surname> <given-names>F</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>CJ</given-names>
</name>
<name>
<surname>Yunker</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Uretsky</surname> <given-names>AD</given-names>
</name>
<etal/>
</person-group>. <article-title>Signal transduction mechanisms mediating secretion in goldfish gonadotropes and somatotropes</article-title>. <source>Biochem Cell Biol</source>. (<year>2000</year>) <volume>78</volume>:<page-range>139&#x2013;53</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/o00-011</pub-id>
</citation>
</ref>
<ref id="B27">
<label>27</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Pemberton</surname> <given-names>JG</given-names>
</name>
</person-group>. <article-title>Comparative aspects of GnRH-stimulated signal transduction in the vertebrate pituitary - contributions from teleost model systems</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2018</year>) <volume>463</volume>:<page-range>142&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2017.06.002</pub-id>
</citation>
</ref>
<ref id="B28">
<label>28</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sefideh</surname> <given-names>FA</given-names>
</name>
<name>
<surname>Moon</surname> <given-names>MJ</given-names>
</name>
<name>
<surname>Yun</surname> <given-names>S</given-names>
</name>
<name>
<surname>Hong</surname> <given-names>SI</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>JI</given-names>
</name>
<name>
<surname>Seong</surname> <given-names>JY</given-names>
</name>
</person-group>. <article-title>Local duplication of gonadotropin-releasing hormone (GnRH) receptor before two rounds of whole genome duplication and origin of the mammalian GnRH receptor</article-title>. <source>PloS One</source>. (<year>2014</year>) <volume>9</volume>:<elocation-id>e87901</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1371/journal.pone.0087901</pub-id>
</citation>
</ref>
<ref id="B29">
<label>29</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname> <given-names>BL</given-names>
</name>
<name>
<surname>Akazome</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Oka</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Eisthen</surname> <given-names>HL</given-names>
</name>
</person-group>. <article-title>Dynamic evolution of the GnRH receptor gene family in vertebrates</article-title>. <source>BMC Evol Biol</source>. (<year>2014</year>) <volume>14</volume>:<elocation-id>215</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12862-014-0215-y</pub-id>
</citation>
</ref>
<ref id="B30">
<label>30</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pawson</surname> <given-names>AJ</given-names>
</name>
<name>
<surname>Katz</surname> <given-names>A</given-names>
</name>
<name>
<surname>Sun</surname> <given-names>YM</given-names>
</name>
<name>
<surname>Lopes</surname> <given-names>J</given-names>
</name>
<name>
<surname>Illing</surname> <given-names>N</given-names>
</name>
<name>
<surname>Millar</surname> <given-names>RP</given-names>
</name>
<etal/>
</person-group>. <article-title>Contrasting internalization kinetics of human and chicken gonadotropin-releasing hormone receptors mediated by C-terminal tail</article-title>. <source>J Endocrinol</source>. (<year>1998</year>) <volume>156</volume>:<fpage>R9</fpage>&#x2013;<lpage>12</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1677/joe.0.156r009</pub-id>
</citation>
</ref>
<ref id="B31">
<label>31</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>X</given-names>
</name>
<name>
<surname>Janovick</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Brothers</surname> <given-names>S</given-names>
</name>
<name>
<surname>Blomenrohr</surname> <given-names>M</given-names>
</name>
<name>
<surname>Bogerd</surname> <given-names>J</given-names>
</name>
<name>
<surname>Conn</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation</article-title>. <source>Mol Endocrinol</source>. (<year>1998</year>) <volume>12</volume>:<page-range>161&#x2013;71</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/mend.12.2.0056</pub-id>
</citation>
</ref>
<ref id="B32">
<label>32</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Toufaily</surname> <given-names>C</given-names>
</name>
<name>
<surname>Fortin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Alonso</surname> <given-names>CA</given-names>
</name>
<name>
<surname>Lapointe</surname> <given-names>E</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>X</given-names>
</name>
<name>
<surname>Santiago-Andres</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Addition of a carboxy-terminal tail to the normally tailless gonadotropin-releasing hormone receptor impairs fertility in female mice</article-title>. <source>Elife</source>. (<year>2021</year>) <volume>10</volume>:<page-range>1&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.7554/eLife.72937</pub-id>
</citation>
</ref>
<ref id="B33">
<label>33</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Oh</surname> <given-names>DY</given-names>
</name>
<name>
<surname>Maiti</surname> <given-names>K</given-names>
</name>
<name>
<surname>Kwon</surname> <given-names>HB</given-names>
</name>
<name>
<surname>Cheon</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hwang</surname> <given-names>JI</given-names>
</name>
<etal/>
</person-group>. <article-title>Involvement of amino acids flanking glu7.32 of the gonadotropin-releasing hormone receptor in the selectivity of antagonists</article-title>. <source>Mol Cells</source>. (<year>2008</year>) <volume>25</volume>:<page-range>91&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S1016-8478(23)17555-8</pub-id>
</citation>
</ref>
<ref id="B34">
<label>34</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Illing</surname> <given-names>N</given-names>
</name>
<name>
<surname>Troskie</surname> <given-names>BE</given-names>
</name>
<name>
<surname>Nahorniak</surname> <given-names>CS</given-names>
</name>
<name>
<surname>Hapgood</surname> <given-names>JP</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Millar</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Two gonadotropin-releasing hormone receptor subtypes with distinct ligand selectivity and differential distribution in brain and pituitary in the goldfish (<italic>Carassius auratus</italic>)</article-title>. <source>Proc Natl Acad Sci U.S.A</source>. (<year>1999</year>) <volume>96</volume>:<page-range>2526&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1073/pnas.96.5.2526</pub-id>
</citation>
</ref>
<ref id="B35">
<label>35</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Du</surname> <given-names>R</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>C</given-names>
</name>
<name>
<surname>Zhang</surname> <given-names>H</given-names>
</name>
<name>
<surname>Xie</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Gao</surname> <given-names>X</given-names>
</name>
<etal/>
</person-group>. <article-title>Novel pituitary actions of GnRH in teleost: the link between reproduction and feeding regulation</article-title>. <source>Front Endocrinol</source>. (<year>2022</year>) <volume>13</volume>:<elocation-id>982297</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2022.982297</pub-id>
</citation>
</ref>
<ref id="B36">
<label>36</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Forfar</surname> <given-names>R</given-names>
</name>
<name>
<surname>Lu</surname> <given-names>ZL</given-names>
</name>
</person-group>. <article-title>Role of the transmembrane domain 4/extracellular loop 2 junction of the human gonadotropin-releasing hormone receptor in ligand binding and receptor conformational selection</article-title>. <source>J Biol Chem</source>. (<year>2011</year>) <volume>286</volume>:<page-range>34617&#x2013;26</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1074/jbc.M111.240341</pub-id>
</citation>
</ref>
<ref id="B37">
<label>37</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Li</surname> <given-names>JH</given-names>
</name>
<name>
<surname>Choe</surname> <given-names>H</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>AF</given-names>
</name>
<name>
<surname>Maiti</surname> <given-names>K</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>C</given-names>
</name>
<name>
<surname>Salam</surname> <given-names>A</given-names>
</name>
<etal/>
</person-group>. <article-title>Extracellular loop 3 (El3) and El3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II</article-title>. <source>Mol Pharmacol</source>. (<year>2005</year>) <volume>67</volume>:<page-range>1099&#x2013;110</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1124/mol.104.004887</pub-id>
</citation>
</ref>
<ref id="B38">
<label>38</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Parhar</surname> <given-names>IS</given-names>
</name>
<name>
<surname>Soga</surname> <given-names>T</given-names>
</name>
<name>
<surname>Sakuma</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Millar</surname> <given-names>RP</given-names>
</name>
</person-group>. <article-title>Spatio-temporal expression of gonadotropin-releasing hormone receptor subtypes in gonadotropes, somatotropes and lactotropes in the cichlid fish</article-title>. <source>J Neuroendocrinol</source>. (<year>2002</year>) <volume>14</volume>:<page-range>657&#x2013;65</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1046/j.1365-2826.2002.00817.x</pub-id>
</citation>
</ref>
<ref id="B39">
<label>39</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dobolyi</surname> <given-names>A</given-names>
</name>
<name>
<surname>Olah</surname> <given-names>S</given-names>
</name>
<name>
<surname>Keller</surname> <given-names>D</given-names>
</name>
<name>
<surname>Kumari</surname> <given-names>R</given-names>
</name>
<name>
<surname>Fazekas</surname> <given-names>EA</given-names>
</name>
<name>
<surname>Csikos</surname> <given-names>V</given-names>
</name>
<etal/>
</person-group>. <article-title>Secretion and function of pituitary prolactin in evolutionary perspective</article-title>. <source>Front Neurosci</source>. (<year>2020</year>) <volume>14</volume>:<elocation-id>621</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnins.2020.00621</pub-id>
</citation>
</ref>
<ref id="B40">
<label>40</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Whittington</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Wilson</surname> <given-names>AB</given-names>
</name>
</person-group>. <article-title>The role of prolactin in fish reproduction</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2013</year>) <volume>191</volume>:<page-range>123&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2013.05.027</pub-id>
</citation>
</ref>
<ref id="B41">
<label>41</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cavagna</surname> <given-names>M</given-names>
</name>
<name>
<surname>Mantese</surname> <given-names>JC</given-names>
</name>
<name>
<surname>Freitas Gda</surname> <given-names>C</given-names>
</name>
<name>
<surname>Dzik</surname> <given-names>A</given-names>
</name>
<name>
<surname>Soares</surname> <given-names>JB</given-names>
</name>
<name>
<surname>Hameiry</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Pattern of Prolactin Secretion after Administration of Gonadotropin-Releasing Hormone Agonist at the Preovulatory Phase of Intrauterine Insemination Cycles</article-title>. <source>Sao Paulo Med J</source>. (<year>2005</year>) <volume>123</volume>:<page-range>295&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1590/s1516&#x2013;31802005000600010</pub-id>
</citation>
</ref>
<ref id="B42">
<label>42</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gordon</surname> <given-names>K</given-names>
</name>
<name>
<surname>Williams</surname> <given-names>RF</given-names>
</name>
<name>
<surname>Danforth</surname> <given-names>DR</given-names>
</name>
<name>
<surname>Veldhuis</surname> <given-names>JD</given-names>
</name>
<name>
<surname>Hodgen</surname> <given-names>GD</given-names>
</name>
</person-group>. <article-title>GnRH antagonists suppress prolactin release in non-human primates</article-title>. <source>Contraception</source>. (<year>1992</year>) <volume>45</volume>:<page-range>369&#x2013;78</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0010&#x2013;7824(92)90059&#x2013;3</pub-id>
</citation>
</ref>
<ref id="B43">
<label>43</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Henderson</surname> <given-names>HL</given-names>
</name>
<name>
<surname>Hodson</surname> <given-names>DJ</given-names>
</name>
<name>
<surname>Gregory</surname> <given-names>SJ</given-names>
</name>
<name>
<surname>Townsend</surname> <given-names>J</given-names>
</name>
<name>
<surname>Tortonese</surname> <given-names>DJ</given-names>
</name>
</person-group>. <article-title>Gonadotropin-Releasing Hormone stimulates Prolactin Release from Lactotrophs in Photoperiodic Species through a Gonadotropin-Independent Mechanism</article-title>. <source>Biol Reprod</source>. (<year>2008</year>) <volume>78</volume>:<page-range>370&#x2013;7</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1095/biolreprod.107.064063</pub-id>
</citation>
</ref>
<ref id="B44">
<label>44</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bogacka</surname> <given-names>I</given-names>
</name>
<name>
<surname>Siawrys</surname> <given-names>G</given-names>
</name>
<name>
<surname>Okrasa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kaminski</surname> <given-names>T</given-names>
</name>
<name>
<surname>Przala</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The influences of GnRH, oxytocin and vasoactive intestinal peptide on LH and PRL secretion by porcine pituitary cells <italic>in vitro</italic>
</article-title>. <source>J Physiol Pharmacol</source>. (<year>2002</year>) <volume>53</volume>:<page-range>439&#x2013;51</page-range>.</citation>
</ref>
<ref id="B45">
<label>45</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Siawrys</surname> <given-names>G</given-names>
</name>
<name>
<surname>Bogacka</surname> <given-names>I</given-names>
</name>
<name>
<surname>Okrasa</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kaminski</surname> <given-names>T</given-names>
</name>
<name>
<surname>Przala</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>The effects of GnRH and adrenergic agents on PRL and &#x3b2;-endorphin secretion by porcine pituitary cells <italic>in vitro</italic>
</article-title>. <source>Acta Vet Hung</source>. (<year>2003</year>) <volume>51</volume>:<page-range>353&#x2013;69</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1556/AVet.51.2003.3.10</pub-id>
</citation>
</ref>
<ref id="B46">
<label>46</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Janovick</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Conn</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Gonadotropin-releasing hormone (GnRH)-receptor coupling to inositol phosphate and prolactin production in GH3 cells stably transfected with rat GnRH receptor complementary deoxyribonucleic acid</article-title>. <source>Endocrinology</source>. (<year>1994</year>) <volume>135</volume>:<page-range>2214&#x2013;9</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.135.5.7956944</pub-id>
</citation>
</ref>
<ref id="B47">
<label>47</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kuphal</surname> <given-names>D</given-names>
</name>
<name>
<surname>Janovick</surname> <given-names>JA</given-names>
</name>
<name>
<surname>Kaiser</surname> <given-names>UB</given-names>
</name>
<name>
<surname>Chin</surname> <given-names>WW</given-names>
</name>
<name>
<surname>Conn</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Stable Transfection of GH3 Cells with Rat Gonadotropin-Releasing Hormone Receptor Complementary Deoxyribonucleic Acid results in Expression of a Receptor coupled to Cyclic Adenosine 3&#x2019;,5&#x2019;-Monophosphate-Dependent Prolactin Release via a G-Protein</article-title>. <source>Endocrinology</source>. (<year>1994</year>) <volume>135</volume>:<page-range>315&#x2013;20</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.135.1.8013367</pub-id>
</citation>
</ref>
<ref id="B48">
<label>48</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stanislaus</surname> <given-names>D</given-names>
</name>
<name>
<surname>Arora</surname> <given-names>V</given-names>
</name>
<name>
<surname>Awara</surname> <given-names>WM</given-names>
</name>
<name>
<surname>Conn</surname> <given-names>PM</given-names>
</name>
</person-group>. <article-title>Biphasic action of cyclic adenosine 3&#x2019;,5&#x2019;- monophosphate in gonadotropin-releasing hormone (GnRH) analog-stimulated hormone release from GH3 cells stably transfected with GnRH receptor complementary deoxyribonucleic acid</article-title>. <source>Endocrinology</source>. (<year>1996</year>) <volume>137</volume>:<page-range>1025&#x2013;31</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.137.3.8603570</pub-id>
</citation>
</ref>
<ref id="B49">
<label>49</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andries</surname> <given-names>M</given-names>
</name>
<name>
<surname>Vande Vijver</surname> <given-names>V</given-names>
</name>
<name>
<surname>Tilemans</surname> <given-names>D</given-names>
</name>
<name>
<surname>Bert</surname> <given-names>C</given-names>
</name>
<name>
<surname>Denef</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Interaction of &#x3b1;T3&#x2013;1 cells with lactotropes and somatotropes of normal pituitary <italic>in vitro</italic>
</article-title>. <source>Neuroendocrinology</source>. (<year>1995</year>) <volume>61</volume>:<page-range>326&#x2013;36</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1159/000126855</pub-id>
</citation>
</ref>
<ref id="B50">
<label>50</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Paul</surname> <given-names>AL</given-names>
</name>
<name>
<surname>Bonaterra</surname> <given-names>M</given-names>
</name>
<name>
<surname>Aoki</surname> <given-names>A</given-names>
</name>
<name>
<surname>Torres</surname> <given-names>AI</given-names>
</name>
</person-group>. <article-title>Cellular and functional interactions between gonadotrophs and lactotrophs in pituitary cell cultures</article-title>. <source>Med Electron Microsc</source>. (<year>2000</year>) <volume>33</volume>:<page-range>231&#x2013;40</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s007950000023</pub-id>
</citation>
</ref>
<ref id="B51">
<label>51</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tipsmark</surname> <given-names>CK</given-names>
</name>
<name>
<surname>Weber</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Strom</surname> <given-names>CN</given-names>
</name>
<name>
<surname>Grau</surname> <given-names>EG</given-names>
</name>
<name>
<surname>Hirano</surname> <given-names>T</given-names>
</name>
<name>
<surname>Borski</surname> <given-names>RJ</given-names>
</name>
</person-group>. <article-title>Involvement of phospholipase C and intracellular calcium signaling in the gonadotropin-releasing hormone regulation of prolactin release from lactotrophs of tilapia (<italic>Oreochromis mossambicus</italic>)</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2005</year>) <volume>142</volume>:<page-range>227&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2004.11.009</pub-id>
</citation>
</ref>
<ref id="B52">
<label>52</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weber</surname> <given-names>GM</given-names>
</name>
<name>
<surname>Powell</surname> <given-names>JF</given-names>
</name>
<name>
<surname>Park</surname> <given-names>M</given-names>
</name>
<name>
<surname>Fischer</surname> <given-names>WH</given-names>
</name>
<name>
<surname>Craig</surname> <given-names>AG</given-names>
</name>
<name>
<surname>Rivier</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Evidence that gonadotropin-releasing hormone (GnRH) functions as a prolactin-releasing factor in a teleost fish (<italic>Oreochromis mossambicus</italic>) and primary structures for three native GnRH molecules</article-title>. <source>J Endocrinol</source>. (<year>1997</year>) <volume>155</volume>:<page-range>121&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1677/joe.0.1550121</pub-id>
</citation>
</ref>
<ref id="B53">
<label>53</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Onuma</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ando</surname> <given-names>H</given-names>
</name>
<name>
<surname>Koide</surname> <given-names>N</given-names>
</name>
<name>
<surname>Okada</surname> <given-names>H</given-names>
</name>
<name>
<surname>Urano</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Effects of salmon GnRH and sex steroid hormones on expression of genes encoding growth hormone/prolactin/somatolactin family hormones and a pituitary-specific transcription factor in masu salmon pituitary cells <italic>in vitro</italic>
</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2005</year>) <volume>143</volume>:<page-range>129&#x2013;41</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.ygcen.2005.03.003</pub-id>
</citation>
</ref>
<ref id="B54">
<label>54</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Taniyama</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kitahashi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ando</surname> <given-names>H</given-names>
</name>
<name>
<surname>Kaeriyama</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Ueda</surname> <given-names>H</given-names>
</name>
<etal/>
</person-group>. <article-title>Effects of gonadotropin-releasing hormone analog on expression of genes encoding the growth hormone/prolactin/somatolactin family and a pituitary-specific transcription factor in the pituitaries of prespawning sockeye salmon</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2000</year>) <volume>118</volume>:<page-range>418&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.2000.7480</pub-id>
</citation>
</ref>
<ref id="B55">
<label>55</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>He</surname> <given-names>M</given-names>
</name>
<name>
<surname>Zhao</surname> <given-names>L</given-names>
</name>
<name>
<surname>Huang</surname> <given-names>T</given-names>
</name>
<name>
<surname>Bian</surname> <given-names>Z</given-names>
</name>
<etal/>
</person-group>. <article-title>Mechanisms for PACAP-induced prolactin gene expression in grass carp pituitary cells</article-title>. <source>J Endocrinol</source>. (<year>2017</year>) <volume>233</volume>:<fpage>37</fpage>&#x2013;<lpage>51</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1530/JOE-16&#x2013;0433</pub-id>
</citation>
</ref>
<ref id="B56">
<label>56</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Ng</surname> <given-names>S</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>RC</given-names>
</name>
<name>
<surname>Ho</surname> <given-names>WK</given-names>
</name>
</person-group>. <article-title>Somatostatin inhibits (D-arg<sup>6</sup>, pro<sup>9</sup>-net) salmon gonadotropin-releasing hormone- and dopamine D1-stimulated growth hormone release from perifused pituitary cells of chinese grass carp, <italic>ctenopharyngodon idellus</italic>
</article-title>. <source>Gen Comp Endocrinol</source>. (<year>1998</year>) <volume>110</volume>:<fpage>29</fpage>&#x2013;<lpage>45</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.1997.7045</pub-id>
</citation>
</ref>
<ref id="B57">
<label>57</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Li</surname> <given-names>W</given-names>
</name>
<name>
<surname>Leung</surname> <given-names>CY</given-names>
</name>
<name>
<surname>Huo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Zhou</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Pituitary adenylate cyclase-activating polypeptide (PACAP) as a growth hormone (GH)-releasing factor in grass carp. I. Functional coupling of cyclic adenosine 3&#x2019;,5&#x2019;-monophosphate and Ca<sup>2+</sup>/calmodulin-dependent signaling pathways in PACAP-induced GH secretion and GH gene expression in grass carp pituitary cells</article-title>. <source>Endocrinology</source>. (<year>2005</year>) <volume>146</volume>:<page-range>5407&#x2013;24</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2005&#x2013;0294</pub-id>
</citation>
</ref>
<ref id="B58">
<label>58</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Fu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
</person-group>. <article-title>Modulation of calmodulin gene expression as a novel mechanism for growth hormone feedback control by insulin-like growth factor in grass carp pituitary cells</article-title>. <source>Endocrinology</source>. (<year>2005</year>) <volume>146</volume>:<page-range>3821&#x2013;35</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/en.2004&#x2013;1508</pub-id>
</citation>
</ref>
<ref id="B59">
<label>59</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Cheung</surname> <given-names>HY</given-names>
</name>
<name>
<surname>Lee</surname> <given-names>EK</given-names>
</name>
<name>
<surname>Chan</surname> <given-names>KM</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>CH</given-names>
</name>
</person-group>. <article-title>Production of recombinant goldfish prolactin and its applications in radioreceptor binding assay and radioimmunoassay</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2002</year>) <volume>126</volume>:<fpage>75</fpage>&#x2013;<lpage>89</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.2001.7771</pub-id>
</citation>
</ref>
<ref id="B60">
<label>60</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Jiang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>G</given-names>
</name>
<name>
<surname>Ko</surname> <given-names>WK</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
</person-group>. <article-title>Grass carp prolactin: molecular cloning, tissue expression, intrapituitary autoregulation by prolactin and paracrine regulation by growth hormone and luteinizing hormone</article-title>. <source>Mol Cell Endocrinol</source>. (<year>2015</year>) <volume>399</volume>:<page-range>267&#x2013;83</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.mce.2014.10.010</pub-id>
</citation>
</ref>
<ref id="B61">
<label>61</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Habibi</surname> <given-names>HR</given-names>
</name>
<name>
<surname>Marchant</surname> <given-names>TA</given-names>
</name>
<name>
<surname>Nahorniak</surname> <given-names>CS</given-names>
</name>
<name>
<surname>van der Loo</surname> <given-names>H</given-names>
</name>
<name>
<surname>Peter</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Rivier</surname> <given-names>JE</given-names>
</name>
<etal/>
</person-group>. <article-title>Functional relationship between receptor binding and biological activity for analogs of mammalian and salmon gonadotropin-releasing hormones in the pituitary of goldfish (<italic>Carassius auratus</italic>)</article-title>. <source>Biol Reprod</source>. (<year>1989</year>) <volume>40</volume>:<page-range>1152&#x2013;61</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1095/biolreprod40.6.1152</pub-id>
</citation>
</ref>
<ref id="B62">
<label>62</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Mylonas</surname> <given-names>CC</given-names>
</name>
</person-group>. <article-title>Endocrine manipulations of spawning in cultured fish: from hormones to genes</article-title>. <source>Aquaculture</source>. (<year>2001</year>) <volume>197</volume>:<fpage>99</fpage>&#x2013;<lpage>136</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0044&#x2013;8486(01)00584&#x2013;1</pub-id>
</citation>
</ref>
<ref id="B63">
<label>63</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yaron</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Gur</surname> <given-names>G</given-names>
</name>
<name>
<surname>Melamed</surname> <given-names>P</given-names>
</name>
<name>
<surname>Rosenfeld</surname> <given-names>H</given-names>
</name>
<name>
<surname>Elizur</surname> <given-names>A</given-names>
</name>
<name>
<surname>Levavi-Sivan</surname> <given-names>B</given-names>
</name>
</person-group>. <article-title>Regulation of fish gonadotropins</article-title>. <source>Int Rev Cytol</source>. (<year>2003</year>) <volume>225</volume>:<page-range>131&#x2013;85</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0074&#x2013;7696(05)25004&#x2013;0</pub-id>
</citation>
</ref>
<ref id="B64">
<label>64</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Blackwell</surname> <given-names>RE</given-names>
</name>
<name>
<surname>Rodgers-Neame</surname> <given-names>NT</given-names>
</name>
<name>
<surname>Bradley</surname> <given-names>EL</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Asch</surname> <given-names>RH</given-names>
</name>
</person-group>. <article-title>Regulation of human prolactin secretion by gonadotropin-releasing hormone <italic>in vitro</italic>
</article-title>. <source>Fertil Steril</source>. (<year>1986</year>) <volume>46</volume>:<fpage>26</fpage>&#x2013;<lpage>31</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/S0015-0282(16)49452-5</pub-id>
</citation>
</ref>
<ref id="B65">
<label>65</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Andries</surname> <given-names>M</given-names>
</name>
<name>
<surname>Denef</surname> <given-names>C</given-names>
</name>
</person-group>. <article-title>Gonadotropin-Releasing Hormone Influences the Release of Prolactin and Growth Hormone from Intact Rat Pituitary <italic>in vitro</italic> during a Limited Period in Neonatal Life</article-title>. <source>Peptides</source>. (<year>1995</year>) <volume>16</volume>:<page-range>527&#x2013;32</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0196-9781(94)00217-T</pub-id>
</citation>
</ref>
<ref id="B66">
<label>66</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sellers</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Smith</surname> <given-names>MS</given-names>
</name>
<name>
<surname>Rojas</surname> <given-names>FJ</given-names>
</name>
<name>
<surname>Asch</surname> <given-names>RH</given-names>
</name>
<name>
<surname>Schally</surname> <given-names>AV</given-names>
</name>
<name>
<surname>Bartke</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Effects of a long-acting LHRH agonist preparation on plasma gonadotropin and prolactin levels in castrated male rats and on the release of prolactin from ectopic pituitaries</article-title>. <source>Regul Pept</source>. (<year>1986</year>) <volume>15</volume>:<page-range>219&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/0167&#x2013;0115(86)90063&#x2013;7</pub-id>
</citation>
</ref>
<ref id="B67">
<label>67</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bhandari</surname> <given-names>RK</given-names>
</name>
<name>
<surname>Taniyama</surname> <given-names>S</given-names>
</name>
<name>
<surname>Kitahashi</surname> <given-names>T</given-names>
</name>
<name>
<surname>Ando</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yamauchi</surname> <given-names>K</given-names>
</name>
<name>
<surname>Zohar</surname> <given-names>Y</given-names>
</name>
<etal/>
</person-group>. <article-title>Seasonal changes of responses to gonadotropin-releasing hormone analog in expression of growth hormone/prolactin/somatolactin genes in the pituitary of masu salmon</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2003</year>) <volume>130</volume>:<fpage>55</fpage>&#x2013;<lpage>63</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0016&#x2013;6480(02)00536&#x2013;1</pub-id>
</citation>
</ref>
<ref id="B68">
<label>68</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mousa</surname> <given-names>MA</given-names>
</name>
<name>
<surname>Mousa</surname> <given-names>SA</given-names>
</name>
</person-group>. <article-title>I mmunohistochemical localization of gonadotropin releasing hormones in the brain and pituitary gland of the nile perch, <italic>lates niloticus</italic> (Teleostei, centropomidae)</article-title>. <source>Gen Comp Endocrinol</source>. (<year>2003</year>) <volume>130</volume>:<page-range>245&#x2013;55</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/s0016&#x2013;6480(02)00611&#x2013;1</pub-id>
</citation>
</ref>
<ref id="B69">
<label>69</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naor</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Huhtaniemi</surname> <given-names>I</given-names>
</name>
</person-group>. <article-title>Interactions of the GnRH receptor with heterotrimeric G proteins</article-title>. <source>Front Neuroendocrinol</source>. (<year>2013</year>) <volume>34</volume>:<fpage>88</fpage>&#x2013;<lpage>94</lpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.yfrne.2012.11.001</pub-id>
</citation>
</ref>
<ref id="B70">
<label>70</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arora</surname> <given-names>KK</given-names>
</name>
<name>
<surname>Cheng</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Catt</surname> <given-names>KJ</given-names>
</name>
</person-group>. <article-title>Mutations of the Conserved DRS Motif in the Second Intracellular Loop of the Gonadotropin-Releasing Hormone Receptor affect its Expression, Activation, and Internalization</article-title>. <source>Mol Endocrinol</source>. (<year>1997</year>) <volume>11</volume>:<page-range>1203&#x2013;12</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/mend.11.9.9968</pub-id>
</citation>
</ref>
<ref id="B71">
<label>71</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ulloa-Aguirre</surname> <given-names>A</given-names>
</name>
<name>
<surname>Stanislaus</surname> <given-names>D</given-names>
</name>
<name>
<surname>Arora</surname> <given-names>V</given-names>
</name>
<name>
<surname>Vaananen</surname> <given-names>J</given-names>
</name>
<name>
<surname>Brothers</surname> <given-names>S</given-names>
</name>
<name>
<surname>Janovick</surname> <given-names>JA</given-names>
</name>
<etal/>
</person-group>. <article-title>The Third Intracellular Loop of the Rat Gonadotropin-Releasing Hormone Receptor couples the receptor to G<sub>s</sub>- and G<sub>q/11</sub>-mediated Signal Transduction Pathways: Evidence from Loop Fragment Transfection in GHH3 Cells</article-title>. <source>Endocrinology</source>. (<year>1998</year>) <volume>139</volume>:<page-range>2472&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.139.5.6022</pub-id>
</citation>
</ref>
<ref id="B72">
<label>72</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rebers</surname> <given-names>FE</given-names>
</name>
<name>
<surname>Bosma</surname> <given-names>PT</given-names>
</name>
<name>
<surname>van Dijk</surname> <given-names>W</given-names>
</name>
<name>
<surname>Goos</surname> <given-names>HJ</given-names>
</name>
<name>
<surname>Schulz</surname> <given-names>RW</given-names>
</name>
</person-group>. <article-title>GnRH stimulates LH Release directly via Inositol Phosphate and indirectly via cAMP in African Catfish</article-title>. <source>Am J Physiol Regul Integr Comp Physiol</source>. (<year>2000</year>) <volume>278</volume>:<page-range>R1572&#x2013;8</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpregu.2000.278.6.R1572</pub-id>
</citation>
</ref>
<ref id="B73">
<label>73</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Steven</surname> <given-names>A</given-names>
</name>
<name>
<surname>Friedrich</surname> <given-names>M</given-names>
</name>
<name>
<surname>Jank</surname> <given-names>P</given-names>
</name>
<name>
<surname>Heimer</surname> <given-names>N</given-names>
</name>
<name>
<surname>Budczies</surname> <given-names>J</given-names>
</name>
<name>
<surname>Denkert</surname> <given-names>C</given-names>
</name>
<etal/>
</person-group>. <article-title>What turns CREB On? and Off? and Why does it matter</article-title>? <source>Cell Mol Life Sci</source>. (<year>2020</year>) <volume>77</volume>:<page-range>4049&#x2013;67</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1007/s00018&#x2013;020-03525&#x2013;8</pub-id>
</citation>
</ref>
<ref id="B74">
<label>74</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Melamed</surname> <given-names>P</given-names>
</name>
<name>
<surname>Haj</surname> <given-names>M</given-names>
</name>
<name>
<surname>Yosefzon</surname> <given-names>Y</given-names>
</name>
<name>
<surname>Rudnizky</surname> <given-names>S</given-names>
</name>
<name>
<surname>Wijeweera</surname> <given-names>A</given-names>
</name>
<name>
<surname>Pnueli</surname> <given-names>L</given-names>
</name>
<etal/>
</person-group>. <article-title>Multifaceted targeting of the chromatin mediates gonadotropin-releasing hormone effects on gene expression in the gonadotrope</article-title>. <source>Front Endocrinol</source>. (<year>2018</year>) <volume>9</volume>:<elocation-id>58</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2018.00058</pub-id>
</citation>
</ref>
<ref id="B75">
<label>75</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>McManus</surname> <given-names>KJ</given-names>
</name>
<name>
<surname>Hendzel</surname> <given-names>MJ</given-names>
</name>
</person-group>. <article-title>CBP, a transcriptional coactivator and acetyltransferase</article-title>. <source>Biochem Cell Biol</source>. (<year>2001</year>) <volume>79</volume>:<page-range>253&#x2013;66</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1139/o01-076</pub-id>
</citation>
</ref>
<ref id="B76">
<label>76</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Newton</surname> <given-names>AC</given-names>
</name>
</person-group>. <article-title>Protein kinase C: perfectly balanced</article-title>. <source>Crit Rev Biochem Mol Biol</source>. (<year>2018</year>) <volume>53</volume>:<page-range>208&#x2013;30</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1080/10409238.2018.1442408</pub-id>
</citation>
</ref>
<ref id="B77">
<label>77</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Stojilkovic</surname> <given-names>SS</given-names>
</name>
<name>
<surname>Bjelobaba</surname> <given-names>I</given-names>
</name>
<name>
<surname>Zemkova</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>Ion channels of pituitary gonadotrophs and their roles in signaling and secretion</article-title>. <source>Front Endocrinol</source>. (<year>2017</year>) <volume>8</volume>:<elocation-id>126</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fendo.2017.00126</pub-id>
</citation>
</ref>
<ref id="B78">
<label>78</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kreutzberger</surname> <given-names>AJB</given-names>
</name>
<name>
<surname>Kiessling</surname> <given-names>V</given-names>
</name>
<name>
<surname>Liang</surname> <given-names>B</given-names>
</name>
<name>
<surname>Seelheim</surname> <given-names>P</given-names>
</name>
<name>
<surname>Jakhanwal</surname> <given-names>S</given-names>
</name>
<name>
<surname>Jahn</surname> <given-names>R</given-names>
</name>
<etal/>
</person-group>. <article-title>Reconstitution of calcium-mediated exocytosis of dense-core vesicles</article-title>. <source>Sci Adv</source>. (<year>2017</year>) <volume>3</volume>:<elocation-id>e1603208</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1126/sciadv.1603208</pub-id>
</citation>
</ref>
<ref id="B79">
<label>79</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xue</surname> <given-names>R</given-names>
</name>
<name>
<surname>Meng</surname> <given-names>H</given-names>
</name>
<name>
<surname>Yin</surname> <given-names>J</given-names>
</name>
<name>
<surname>Xia</surname> <given-names>J</given-names>
</name>
<name>
<surname>Hu</surname> <given-names>Z</given-names>
</name>
<name>
<surname>Liu</surname> <given-names>H</given-names>
</name>
</person-group>. <article-title>The role of calmodulin vs synaptotagmin in exocytosis</article-title>. <source>Front Mol Neurosci</source>. (<year>2021</year>) <volume>14</volume>:<elocation-id>691363</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.3389/fnmol.2021.691363</pub-id>
</citation>
</ref>
<ref id="B80">
<label>80</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Creamer</surname> <given-names>TP</given-names>
</name>
</person-group>. <article-title>Calcineurin</article-title>. <source>Cell Commun Signal</source>. (<year>2020</year>) <volume>18</volume>:<fpage>137</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1186/s12964&#x2013;020-00636&#x2013;4</pub-id>
</citation>
</ref>
<ref id="B81">
<label>81</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Van Goor</surname> <given-names>F</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Entry of extracellular calcium mediates dopamine D1-stimulated growth hormone release from goldfish pituitary cells</article-title>. <source>Gen Comp Endocrinol</source>. (<year>1994</year>) <volume>94</volume>:<page-range>316&#x2013;28</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1006/gcen.1994.1088</pub-id>
</citation>
</ref>
<ref id="B82">
<label>82</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
<name>
<surname>Van Goor</surname> <given-names>F</given-names>
</name>
<name>
<surname>Jobin</surname> <given-names>RM</given-names>
</name>
<name>
<surname>Neumann</surname> <given-names>CM</given-names>
</name>
<name>
<surname>Chang</surname> <given-names>JP</given-names>
</name>
</person-group>. <article-title>Interactions of cyclic adenosine 3&#x2019;,5&#x2019;-monophosphate, protein kinase-C, and calcium in dopamine- and gonadotropin-releasing hormone-stimulated growth hormone release in the goldfish</article-title>. <source>Endocrinology</source>. (<year>1994</year>) <volume>135</volume>:<page-range>1593&#x2013;604</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1210/endo.135.4.7925122</pub-id>
</citation>
</ref>
<ref id="B83">
<label>83</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname> <given-names>Q</given-names>
</name>
<name>
<surname>He</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wang</surname> <given-names>X</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
</person-group>. <article-title>Grass carp somatolactin: II. Pharmacological study on post-receptor signaling mechanisms for PACAP-induced somatolactin &#x3b1; and &#x3b2; Gene expression</article-title>. <source>Am J Physiol Endocrinol Metab</source>. (<year>2008</year>) <volume>295</volume>:<page-range>E477&#x2013;90</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpendo.90386.2008</pub-id>
</citation>
</ref>
<ref id="B84">
<label>84</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huo</surname> <given-names>L</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AO</given-names>
</name>
</person-group>. <article-title>Genomic structure and transcriptional regulation of grass carp calmodulin gene</article-title>. <source>Biochem Biophys Res Commun</source>. (<year>2009</year>) <volume>390</volume>:<page-range>827&#x2013;33</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1016/j.bbrc.2009.10.057</pub-id>
</citation>
</ref>
<ref id="B85">
<label>85</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lin</surname> <given-names>C</given-names>
</name>
<name>
<surname>Bai</surname> <given-names>J</given-names>
</name>
<name>
<surname>He</surname> <given-names>M</given-names>
</name>
<name>
<surname>Wong</surname> <given-names>AOL</given-names>
</name>
</person-group>. <article-title>Grass carp prolactin gene: structural characterization and signal transduction for PACAP-induced prolactin promoter activity</article-title>. <source>Sci Rep</source>. (<year>2018</year>) <volume>8</volume>:<fpage>4655</fpage>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/s41598&#x2013;018-23092&#x2013;0</pub-id>
</citation>
</ref>
<ref id="B86">
<label>86</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname> <given-names>A</given-names>
</name>
<name>
<surname>Rahman</surname> <given-names>G</given-names>
</name>
<name>
<surname>Gorelik</surname> <given-names>J</given-names>
</name>
<name>
<surname>Bhargava</surname> <given-names>A</given-names>
</name>
</person-group>. <article-title>Voltage-gated T-type calcium channel modulation by kinases and phosphatases: the old ones, the new ones, and the missing ones</article-title>. <source>Cells</source>. (<year>2023</year>) <volume>12</volume>:<page-range>1&#x2013;23</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.3390/cells12030461</pub-id>
</citation>
</ref>
<ref id="B87">
<label>87</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sang</surname> <given-names>L</given-names>
</name>
<name>
<surname>Dick</surname> <given-names>IE</given-names>
</name>
<name>
<surname>Yue</surname> <given-names>DT</given-names>
</name>
</person-group>. <article-title>Protein kinase A modulation of cav1.4 calcium channels</article-title>. <source>Nat Commun</source>. (<year>2016</year>) <volume>7</volume>:<elocation-id>12239</elocation-id>. doi:&#xa0;<pub-id pub-id-type="doi">10.1038/ncomms12239</pub-id>
</citation>
</ref>
<ref id="B88">
<label>88</label>
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Keef</surname> <given-names>KD</given-names>
</name>
<name>
<surname>Hume</surname> <given-names>JR</given-names>
</name>
<name>
<surname>Zhong</surname> <given-names>J</given-names>
</name>
</person-group>. <article-title>Regulation of cardiac and smooth muscle Ca<sup>2+</sup> Channels (Ca<sub>V</sub>1.2a,b) by protein kinases</article-title>. <source>Am J Physiol Cell Physiol</source>. (<year>2001</year>) <volume>281</volume>:<page-range>C1743&#x2013;56</page-range>. doi:&#xa0;<pub-id pub-id-type="doi">10.1152/ajpcell.2001.281.6.C1743</pub-id>
</citation>
</ref>
</ref-list>
</back>
</article>